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         Abstracts 
Abstract 
Spinal Cord Injury (SCI) is a devastating disease which leads to long lasting 
neurological deficits including sensory and motor-dysfunction below the site of injury. The 
persistence of these deficits is due to the low capacity of the adult central nervous system 
(CNS) to regenerate after injury. However, over the last decade it has been shown, that axonal 
tracts in the spinal cord can in principle remodel after injury. The corticospinal tract (CST), an 
important descending motor tract that is involved in the fine movement and coordination of 
the fore- and hindlimbs, serves as a good model to study this remodeling. A key aspect of 
CST remodeling after injury is the formation of intraspinal detour circuits that contribute to 
functional recovery. Which molecules regulate the formation of these new detour circuits is so 
far unknown. In my thesis, I aimed to identify these regulatory molecules and to understand 
their contribution to the establishment of detour circuits after injury.  
First, I investigated, whether activating the intrinsic growth program can induce de 
novo sprouting of CST collaterals and thereby improve functional recovery. To do so, I 
induced sustained expression of STAT3, a growth-promoting transcription factor, via viral 
gene transfer in cortical projection neurons. This allowed me to show that enhanced activation 
of the intrinsic growth program was sufficient to increase sprouting of CST collaterals after 
injury.  
Second, I performed in situ hybridizations for guidance and synaptogenic molecules to 
screen for candidates that could influence targeting of CST collaterals following spinal cord 
injury. I can show that all the molecules studied are also expressed in the adult CNS and that 
several cues among them, Semaphorin 7a, SynCAM4, Slits and Neuroligin 1, are 
differentially expressed in subsets of spinal interneurons suggesting that they could be 
involved in target finding during detour circuit formation. 
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Finally, I focused our attention on the establishment of new synapses during post-
injury detour circuit formation. Recently, the family of fibroblast growth factors (FGF’s) has 
been shown to be important during presynaptic differentiation in the development of the 
cerebellum and CA3 pyramidal neurons in the hippocampus. FGF22 in particular can promote 
the establishment of excitatory synapses and therefore is an interesting candidate that could 
regulate the formation of CST synapses during post-injury remodeling. To test this, I deleted 
the FGF22 ligand (using FGF22KO mice) or specifically ablated its main receptors, FGFR1 
and FGFR2, in the hindlimb CST. Deleting FGF22 or both receptors impaired bouton 
formation and maturation of the newly formed CST collaterals and as a result limited the 
formation of detour circuits following spinal cord injury. This leads to a profound delay of 
functional recovery in mutant mice after spinal cord injury. These results identify FGF22 
signaling as a first regulator of synapse formation during axon remodeling in the injured adult 
central nervous system.   
In summary, the results presented in my thesis provide new insights into the molecular 
regulation of detour circuit formation and identify promising therapeutic targets (such as 
STAT3 and FGF22) that can foster axonal remodeling after spinal cord injury.         
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Zusammenfassung 
Eine Rückenmarksverletzung hat für die betroffenen Patienten verheerende Folgen 
und führt häufig zu dauerhaften sensorischen und motorischen Funktionsausfällen unterhalb 
der Verletzungsstelle. Diese Funktionsausfälle sind häufig dauerhaft, da 
Nervenzellverbindungen im  zentralen Nervensystem des Erwachsenen nicht mehr 
regenerieren können. In den letzten Jahren konnte jedoch gezeigt werden, dass 
Nervenzellverbindungen im Rückenmark nach einer Verletzung dazu fähig sind sich zu 
reorganisieren. Der kortikospinale Trakt  (CST), ein wichtiger herabsteigender Fasertrakt, der 
die Ausführung der Feinmotorik und die Abstimmung der Extremitäten koordiniert, ist dabei 
ein besonders gutes Model zur Untersuchung dieser neuronalen Umstrukturierung. So konnte 
gezeigt werden, dass der CST nach einer Durchtrennung einen intraspinalen 
„Umgehungskreislauf“ bildet und damit schließlich zur funktionellen Erholung beiträgt. 
Welche Moleküle die Bildung dieses Umschaltkreislaufes regulieren, ist soweit nicht bekannt. 
In meiner Doktorarbeit habe ich entsprechend versucht erste Signalwege zu identifizieren, 
welche bei der Umstrukturierung nach einer Rückenmarksläsion eine Rolle spielen.  
Im ersten Teil meiner Arbeit, untersuchte ich, ob die Aktivierung des intrinsischen 
neuronalen Wachstumsprogramms die Ausbildung neuer CST Kollateralen veranlassen kann. 
Dazu induzierten wir eine andauernde Expression von STAT3, einen wachstumssteigernden 
Transkriptionsfaktor, in kortikalen Projektionsneuronen mittels viralen Gentransfer und 
konnten zeigen, dass dies zu einer vermehrten Aussprossung neuer CST Kollaterale nach 
einer Läsion führt.  
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Im zweiten Teil meiner Arbeit führte ich einen in situ Hybridisierungs-Screen durch, 
um potentielle Kandidaten, welche das gerichtete Wachstum von Axonen und die Herstellung 
von synaptischen Verbindungen nach einer Rückenmarksverletzung fördern könnten, zu 
identifizieren. Ich konnte zeigen, dass alle untersuchten Moleküle, die während der 
Entwicklung des ZNS das gerichtete Wachstum von neuronalen Verbindungen steuern, auch 
im adulten ZNS exprimiert werden. Einige dieser  Moleküle, unter anderem Semaphorin 7a, 
SynCAM4, Mitglieder der Slit Familie und Neuroligin1, zeigen ein interessantes 
Expressionsmuster, welches auf deren mögliches Mitwirken bei der Entstehung intraspinaler 
Umgehungskreisläufe hindeuten kann. 
Im letzten Abschnitt meiner Arbeit, untersuchte ich, welche Moleküle die Ausbildung 
neuer Synapsen nach einer Läsion steuern. Vor kurzem wurde entdeckt, dass die Familie der 
Fibroblasten Wachstumsfaktoren (FGFs) eine wichtige Rolle während der präsynaptischen 
Differenzierung im Kleinhirn und Hippocampus spielen. Insbesondere für FGF22 konnte 
gezeigt werden, dass es die Ausbildung von exzitatorischen Synapsen induzieren kann und 
somit möglicherweise auch die Bildung neuer Synapsen des CSTs beeinflussen könnte. Um 
dies zu untersuchen, habe ich Mäuse verwendet, die entweder FGF22 defizient waren (FGF22 
KO Mäuse) oder in denen die beiden FGF22 Rezeptoren, FGFR1 und FGFR2, in den 
Neuronen des Hinterbein-CST genetisch entfernt wurden. Unsere Ergebnisse zeigen, dass das 
Fehlen von FGF22 oder seiner Rezeptoren nach einer Läsion bei den neu auswachsenden 
CST Kollateralen zu einer deutlichen Reduktion der Synapsenbildung  und – Reifung führt. 
Dies behindert entsprechend die Ausbildung der intraspinalen Umgehungskreisläufe und 
verzögert die funktionelle Erholung nach einer Rückenmarksverletzung. Unsere Ergebnisse 
identifizieren den FGF22-FGFR Signalweg als einen wichtigen Regulator der Neubildung 
von Synapsen im geschädigten zentralen Nervensystem des Erwachsenen. 
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In der Gesamtschau geben die Ergebnisse meiner Arbeit neue Einblicke in die 
molekulare Regulation der Ausbildung von Umgehungskreisläufe und neue Hinweise auf 
vielversprechende therapeutische Ansätze (mit STAT3 oder FGF22), die die 
Umstrukturierung von Nervenzellverbindungen nach einem Rückenmarkstrauma verbessern 
könnten.  
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Chapter 1 
1. Introduction 
1.1 Epidemiology of Spinal Cord Injury (SCI) 
With an occurrence of 18.5 people/million (source: The International Campaign for Cures of 
spinal cord injury Paralysis, ICCP), spinal cord injury impacts about 3000 new cases in 
Germany every year (Köning and Frowein, 1989). Surviving a traumatic injury of the spinal 
cord is most often followed by a “new” life in a wheelchair and the person usually depends on 
other people’s help for the rest of her / his life. Most of the patients are young males (70%) 
with an average age between 16 and 30 years (Hulsebosch et al., 2002; Sadowsky et al., 
2002). Most of the traumatic injuries occur due to accidents (2/3 of all cases), i.e. sports, 
traffic or work (Figure 1).  In addition to striking life changing circumstances for the patient, 
the economic impact, in terms of long term cost of care and cost of social welfare support, 
reaches a high level every year (Westgren and Levi, 1998). For example, the costs for the 
United States alone reach up to 7.7 billion dollars annually (National Spinal Cord Injury 
Statistical Center, University of Alabama at Birmingham). 
 
 
 
 
 
 
 
 
Figure 1: Causes of Spinal Cord 
Injuries; Over 50% of SCI are caused 
by accidents, one half by vehicle (i.e. 
motorbike) or during work (reprint 
permission from Christopher Reeve 
Foundation). 
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An insult to the spinal cord results in a change of the normal motor, sensory or autonomic 
function. This can be temporary or permanent as well as either complete or incomplete 
(Classification in the ASIA impairment scale, Figure 2). A complete injury leads to a total and 
irreversible loss of voluntary movement and sensation below the segment of injury. After an 
incomplete injury however, some function below the segment of injury remains (Raineteau 
and Schwab, 2001; Fawcett et al., 2007). Thereby in incomplete injuries some degree of 
spontaneous functional recovery in patients might be observed (Wernig and Müller, 1992; 
Dietz et al., 1998). These injuries are of course more amenable to therapies than complete 
injuries. The level where the injury occurs is also crucial, as this can either lead to paraplegia 
or quadriplegia (Figure 2). An injury at the level of the cervical spinal cord (between C1 and 
C7) causes quadriplegia, which happens in 52% of all cases and is classified by a loss of use 
of all four limbs and torso. A lower level of injury (between T1 and L5) instead leads to 
paraplegia, which happens in 47% of all cases and causes impairment in motor and sensory 
function of the lower extremities.   
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Spinal cord injury classification according to the American Spinal Injury 
Association (ASIA) Impairment Scale (Modified from Thuret et al., 2006; reprint 
permission from Nature Publishing Group) 
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1.2 Clinical Treatments to Date 
Clinical treatments and strategies which are currently available do not lead to full recovery of 
sensory and motor function after spinal cord injury. However, they are designed to prevent 
secondary damage, help recovery as much as possible and usually are targeting different 
pathophysiological phases following the injury. 
1.2.1 Pathophysiology of SCI     
A spinal trauma leads to spinal vertebrate luxation or the break of spinal bones and thereby to 
a local injury of the spinal cord with a disruption of spinal nerve tracts (primary damage). 
This phase, directly after the insult, is called acute phase or spinal shock and includes the 
momentary complete loss of all reflexes, a reduced blood flow and a change of the whole 
biochemical environment (Ditunno et al., 2004; Martirosyan et al., 2011). The acute phase is 
quickly followed by the sub-acute phase which is featured by the release of free radicals, an 
inflammatory response with the influx of macrophages and the development of a vasogenous 
as well as a cytotoxic edema (Dusart and Schwab, 1994; Bethea and Dietrich, 2002; Sharma 
and Olsson, 1990). In the ensuing late phase a scar is formed, which includes the appearance 
of reactive astrocytes, necrosis, apoptosis, Wallerian degeneration (Zhang et al., 1997), 
demyelination and expression of growth inhibitory factors like Nogo-A and OMg or MAGs in 
the vicinity of the scar that inhibit regeneration at the lesion site (secondary damage; Filbin, 
2003; Pernet and Schwab, 2012) (Figure 3).  
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1.2.2   Clinical Intervention to SCI  
Depending on the phase in which the patient is, there are different strategies which are 
applied to avoid the spread of nerve degeneration or to induce functional recovery as much as 
possible.  
 
 
 
 
 
 
 
 
 
 
 
 
In the acute and sub-acute phase, the first step is to remove mechanical causes, like broken 
bones during a reconstructive surgery. After that, most of the patients in many countries 
receive a cocktail of corticosteroids including methylprednisolone (MPS), which is designed 
to decrease inflammation and the release of free radicals. It is supposed to lead to fundamental 
increased functional recovery if applied within 8hrs after trauma (Bracken et al., 1984; 
Bracken et al., 1990; Bracken et al., 1997). Today this therapy is considered controversial and  
Figure 3: Phases of Spinal Cord Injury. The acute phase, with destruction of BBB and 
hemorrhage development. The sub-acute phase, with release of free radicals and NO plus 
inflammatory response. And finally the chronic phase, including glia scar formation. (Modified 
from Nakamura and Okano, 2013; Re-print permission from Nature Publishing Group) 
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often withdrawn as long term studies showed low efficiency, strong side effects (Hurlbert and 
Hamilton, 2008) such as diabetes mellitus, osteoporosis and psychosis and several follow up 
studies couldn’t reproduce the beneficial long term effects which had been shown in the first 
studies of the NASCIS (National Acute Spinal Cord Injury Study I and II) (George et al., 
1995; Gerhart et al., 1995; Nesathurai et al., 1998; Shepard et al., 1994; Hurlbert, 2008). 
Considering these insecurities and potential risks, a lot of effort is put into finding new 
therapeutic treatments. More recently an additional drug has been shown to be glia- and 
neuro-protective – Asialoerythropoetin (AsialoEPO). Here, the reduction of secondary 
damage, such as apoptosis, the inflammation processes and the ability to restore vascular 
integrity (for review see Matis and Birbilis, 2008; Mofidi et al., 2011) has been shown in 
experimental models for SCI and thereby showing exceptional preclinical characteristics and 
giving high promises into clinical human trials. 
The chronic time after the acute phase is usually accompanied with trying to re-activate neural 
connections that have been destroyed due to the injury. Here, the only therapeutic intervention 
that is standard of care and internationally applied to maximize functional recovery in human 
SCI is rehabilitative training, such as weight-supported treadmill training (Edgerton et al, 
2004; Dietz and Harkema, 2004; Dietz and Fouad, 2014). The treadmill training has shown 
some success in patients with functionally incomplete spinal cord injury (ASIA B-D) and 
therefore became routine in the rehabilitation centers. The body weight supporting harness 
and the movement of the legs via a robot or physiotherapist leads to a restoring of natural 
walking and a sensory feedback input (Maegele et al., 2002; Dietz et al., 2010). The 
improvements of locomotor capability depend on the location and on the size of the injury 
(Wernig et al., 1998); however they are maintained over a long period of time. Patients with  
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complete injury, unfortunately, haven’t been able to maintain stepping movements after the 
training sessions were finished (Wirz et al., 2001). 
1.3 Experimental Models to study Spinal Cord Injury 
Trying to understand what happens within the injured human spinal tissue is studied in 
experimental models in order to discover different therapeutic treatments. Some studies focus 
on the prevention of toxicity, apoptosis or inflammation and hence are all driven by the aim to 
reduce cell death and scar formation (Kigerl et al., 2009; Liu et al., 1997; Nicholson et al., 
2000; Fitch et al. 1999; Popovich et al., 1999). Others are trying to promote axonal growth 
and regeneration, and thereby restore function. For instance, attempts are carried out in which 
grafts that can bridge the lesion sites are applied directly after the injury and into the lesion 
area so that the injured fibers are able to regrow along those (Li et al., 1998; Bamber et al., 
2001; Taylor et al., 2006).  
Another strategy is to neutralize the growth inhibiting environment of the scar by applying 
IN-1 antigen, a blocker for the neurite growth inhibitor Nogo-A. In doing so, regeneration of 
sprouting fibers and their growth over longer distances is seen (Schnell and Schwab, 1990; 
Brösamle et al., 2000; Chen et al., 2000). In contrast to  block inhibition, other studies apply 
growth promoting factors such as neurotrohpins (BNDF or NT3) (Jakeman et al., 1998; Jain 
et al., 2005; Sasaki et al., 2009; Houweling et al., 1998; Novikova et al., 2000) or gene 
transcription factors inducing axonal growth (Bareyre et al. 2011) after injury to promote 
induction of axonal growth. All these studies show promising potential to either be transferred 
into clinical studies at some point or at least to help us gain a greater insight into the 
pathophysiology of spinal cord injury.  
 
14 
 
           Chapter 1 
The different attempts mentioned above are carried out in experimental animal models of SCI 
and are crucial to a better understanding of human injuries. Indeed experimental designs are 
trying to model the physical processes by which human SCI occurs and to replicate the 
variety of chronic pathologies that characterize its long term effects (Stokes and Jakeman, 
2002; Filis and Schwab, 2012). The variations in biological processes between species 
contribute to difficulties in generalizing only one experimental model and its findings to the 
human condition. Therefore, depending on the question that is to be answered, different 
models are chosen. For example, is the primary focus of the experiment fiber regeneration and 
sprouting, or is the focus of the study on neuroprotective investigations? 
 1.3.1 Contusion Injury 
The contusion injury is the most commonly used model to study SCI. Here, a determined 
weight is dropped onto the exposed spinal cord (New York University – Multicenter Animal 
Spinal Cord Injury Studies (NYU-MASCIS) impactor device). With different standardized 
weights one can mimic defined grades of spinal cord injury. The outcomes of this injury are 
very similar to human injuries, a necrotic center which is surrounded by histologically 
normal-appearing myelinated fibers and portions of gray matter (Figure 4a). The cell loss 
starts immediately after the initial impact and continues radially in all directions so that the 
lesion expands over time (several days to weeks). This expanded time frame of cell loss offers 
an opportunity for therapeutic intervention to rescue the neural cell populations (Hulsebosch 
2002). 
1.3.2 Dorsal Hemisection Injury  
The second, most common, used model is the dorsal hemisection. It is a model to precisely 
and reproducibly study SCI. Here, the dorsal spinal cord is transected with a very fine pair of  
15 
 
           Chapter 1 
scissors (iridectomy scissors). To induce paralysis of the hindlimbs in the mouse model, 
which represents humans paralysis the best and easiest, the hemisection is usually placed at a 
thoracal level of T8 – T9 (Figure 4b). This model induces a precise and local lesion with very 
defined histological consequences and spares parts of the cord. This sparing of parts of the 
spinal cord also represents a hallmark of most SCI in humans. Due to the mentioned 
advantages above, the dorsal hemisection is a very suitable model to study axonal 
regeneration at the lesion site as well as axon remodeling or reorganization (Bareyre et al., 
2004).  
1.3.3 Full Lesion Injury  
A full or complete lesion injury is the term used to describe a complete transection of the 
spinal cord. Here the spinal cord is also transected with a fine pair of scissors, but no tissue is 
spared. Following the injury, the two stomps of the spinal cord retract leaving a “gap” 
between the two spinal extremities. It results in a complete and permanent loss of the ability 
to send sensory and motor impulses to the region below the lesion site and is also a very good 
model to study axonal regeneration at the lesion site. However it is noteworthy to say, that 
even in complete lesion models, some axons might be left intact in the ventral part of the 
spinal cord (You et al., 2003). 
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1.4 Axonal Remodeling following SCI 
For a long time it has been postulated that the adult CNS is not able to remodel or reorganize 
after a CNS injury, i.e. after traumatic brain injury or SCI. Over the last years this dogma has 
been proven wrong. First studies in mice could show some spontaneous recovery after injury 
which also to some extend happens in humans (Burns et al., 1997; Dietz et al., 1998; Dietz 
2002; Curt et al., 2004; Fouad et al., 2001). Most of the studies, that show this potential of 
plasticity, have been investigating spinal cord lesions, in particular lesions of the corticospinal 
tract (CST) (Terashima et al., 1995; Weidner et al., 2001; Fouad et al., 2001; Bareyre et al., 
2004; Courtine et al., 2008; Lang et al., 2012).  
Figure 4: Models to study SCI. a) Contusion Injury; Mechanical device (MASCIS Impactor) 
and representative cross sections from the lesion center (GFAP staining) (adapted from Ishii et 
al., 2012). b) Dorsal Hemisection; Induction of a lesion with a pair of fine iridectomy scissors 
leads to transection of dorsal part of spinal cord, thereby leaving the ventral part intact (as 
indicated in bottom images from Lang et al., 2012). 
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1.4.1  Anatomy of the Corticospinal Tract (CST) 
The corticospinal tract (CST) is one of the major descending pathways from the motor cortex 
down to the spinal cord. The mammalian CST controls fine movements like grasping or 
stepping. It originates in the pyramidal cells of layer V of the motorcortex. About 95% of 
these cells send their axons down to the spinal cord via the brain stem and cross over to the 
contralateral side (pyramidal decussation) at the end of the medulla oblongata 
(spinomedullary junction in the mouse). In humans they cross at the level of the lateral 
funiculi and form the lateral corticospinal tract, whereas in the mouse they form the main CST 
(Terashima, 1995). The left over 5% of the axons do not cross contralaterally and thereby 
travel ipsilaterally in the white matter down to the spinal cord. Once the axons reached their 
target area in the spinal cord, they branch into the gray matter and connect (most of the time 
via interneurons) to the lower motor neurons in the ventral horn. Depending on their target 
area, the fibers are divided into the forelimb CST and hindlimb CST. The forelimb CST 
terminates in the cervical spinal cord (C3-C5 level), the hindlimb CST terminates in the 
lumbar spinal cord (L1-L5).  
1.4.2  Detour Circuit Formation 
The establishments of new circuits in the CNS to overcome or bypass a lesion, and thereby 
forming new circuits, have been shown in several publications over last decade. In 2001, 
Fouad et al. could show that after an incomplete thoracic hemisection, the CST is able to form 
new collaterals in the cervical region (C3-C5) (Fouad et al., 2001). That this sprouting is 
functionally meaningful was shown a couple of years later by Bareyre et al. in 2004. Here the 
authors demonstrated the establishment of a detour circuit which is formed by contacts of the 
newly born collaterals onto long propriospinal neurons (LPSN) which extend their axons from  
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C3-C5 in the ventral and lateral horn (Giovaneli Barilari and Kypers, 1969) down to the 
lumbarsacral enlargement (Alstermark et al., 1987; Dietz et al., 2002) (Figure 5). The LPSN 
are known to coordinate forelimb and hindlimb movements (Jankowska et al., 1974; Grillner 
et al., 1975). These interneurons are spared by an incomplete, dorsal hemisection and are able 
to transduce signals coming from the new CST collaterals onto the hindlimb motoneurons 
hence creating a new circuit (Bareyre et al., 2004) (Figure 5c+d). Electrophysiological 
experiments demonstrated that information coming from the cortex can be transmitted to the 
hindlimb motoneurons. Also the authors show in behavioral experiments that spontaneous 
functional recovery at least in parts is mediated by the detour circuit formation (Bareyre et al., 
2004). 
The importance of newly formed intraspinal circuits has been further strengthened by several 
publications investigating the spontaneous axonal plasticity of the corticospinal tract after 
injury (Weidner et al., 2001; Courtine et al., 2008). A recent publication from van den Brand 
et al., (2012) for instance shows that plasticity and recovery can take place also in cases of 
severe spinal cord injury. Here, after two lateral lesions in the thoracal spinal cord, they 
injected a chemical solution of monoamine agonists which triggers cell responses of spinal 
neurons and replaces the neurotransmitter cocktail which would come from the brainstem 
pathways in the healthy mouse. The cocktail is able to induce activation of lower spinal 
intercircuits and thereby of lower body movement. The authors then electrically stimulated 
the spinal cord with electrodes implanted in the spinal canal. This localized stimulation sends 
continuous electrical signals through nerve fibers to the chemically excited neurons. After a 
couple of weeks of training the rats not only voluntary initiated walking but also were able to 
climb obstacles and steps. They could show that this recovery is also due to a strong  
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remodeling process of supraspinal and intraspinal connections as well as cortical projections 
from the CST (van den Brand et al., 2012).  
Intraspinal remodeling can not only be shown following traumatic lesions of the spinal cord 
but also following inflammatory lesions of the spinal cord. In an animal model of multiple 
sclerosis model (EAE), it has been shown that the CST can show sprouting ability above the 
inflammatory lesion. This leads to a detour circuit formation due to the increased contact 
formation onto spinal interneurons surrounding the lesion site and in the lumbar target area 
(Kerschensteiner et al., 2004). An additional paper supports this remodeling by showing the 
sprouting ability of the CST along blood vessels after EAE induction (Muramatsu et al., 
2012). 
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Figure 5. Model of Detour Circuit Formation. a) Unlesioned hindlimb CST (hCST) travels 
down the spinal cord and sends sprouts into the gray matter of the lumbar enlargement. b) 
After dorsal hemisection (T8) regeneration of collaterals from lesion site fails. Instead the 
lesion leads to spontaneous sprouting of the hCST in the cervical spinal cord (C3-C5). c) 3wks 
after lesion new collaterals form contacts onto excitatory spinal interneurons (SPSN and 
LPSN). d) 12wks after lesion only contacts onto LPSN remain, which run in the ventral horn 
and thereby are able to bridge the lesion site. Also the number of contacts onto the hindlimb 
motoneurons increases (Harel and Strittmater, 2006; Re-print permission from Nature 
Publishing Group). 
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The last decade of research has shown that the spinal cord after an injury has the capability to 
spontaneously form new intraspinal circuits (Fouad et al., 2002; Bareyre et al., 2004; 
Kerschensteiner et al., 2004; Courtine et al., 2008; van den Brand et al., 2012). Studying this 
process in further detail and thereby learning more about intrinsic factors, which might play a 
key role for the establishment of such circuits, will be important in coming one step closer to 
potential therapeutic treatments for human spinal cord injury.   
For the successful formation of the detour circuit after a dorsal hemisection (Bareyre 
et al., 2004), several steps are required. 
  1.4.2.1  Directed Axonal Growth 
In the first phase of the detour circuit formation, the newly born axon collaterals have to know 
where to grow to and thereby find their target area. In case of the detour circuit formation 
after a dorsal SCI, they have to grow into ventral-medial part of the cervical spinal cord, 
where the cell bodies of the LPSNs originate (Alstermark et al., 1987). First, the axons need 
to initiate growth which is possibly promoted via growth promoting molecules such as 
STAT3 or Semaphorin 7a. Second, once the axons have initiated growth, these need to be 
guided toward their appropriate target cells. Several molecules that induce axonal outgrowth 
and axon guidance have been shown to be important during neural development (for review 
Niclou et al., 2006; Guan and Rao, 2003), among others Netrins (Kennedy et al., 2006), 
Semaphorins (Behar et al., 1996), Slits (Lopez-Bendito et al., 2007) and Ephrins (Eberhart et 
al., 2000). Also, first studies now show their expression in the adult CNS, indicating a 
potential important role in injury induced spinal remodeling (Wehrle et al., 2005; Marillat et 
al., 2002; Mann et al., 2007; Bundesen et al., 2003). 
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1.4.2.2 Synapse Formation 
Once the axon collaterals have reached their target cells, they have to contact those. This 
process is called synapse formation and requires a very defined course of events. To date it is 
not entirely clear which exact time course synapse formation follows, but studies conducted 
during CNS development agree that it can either be induced pre-synaptically or post-
synaptically (Gerrow and El-Husseini, 2006).  
Presynaptic-induced formation usually starts with the recruitment of presynaptic molecules 
upon initial contact (presynaptic differentiation) such as molecules for the assembly of the 
vesicle release machinery. This phase is followed by the creation of an active zone and the 
accumulation on the postsynaptic density (postsynaptic differentiation). The postsynaptic-
induced synapse formation first recruits preformed postsynaptic scaffold proteins upon initial 
contact which then signals the presynaptic machinery to assemble. Either way, the recruitment 
of receptors to the postsynaptic side represents the last phase of the synapse formation. There 
are several molecules which are known to be important for the process of synapse formation 
during the development of the CNS, such as SynCams (Biederer et al., 2002), Neuroligins 
(Scheiffele et al., 2000) or FGF’s (Umemori et al, 2004), which act as presynaptic organizers 
and EphrinBs (Henkemeyer et al., 2003) or Neurexins (Graf et al., 2004), which can act as 
postsynaptic organizers (Dalva et al, 2007; Shapiro et al., 2007; Tallafuss et al., 2010). 
Whether these are also important during contact formation after SCI, has been started to be 
investigated in the last couple of years (Thomas et al., 2008, Zelano et al., 2007, Budensen et 
al., 2003, Moreno-Flores et al., 1999). 
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1.4.3   Molecular Regulation of Detour Circuit Formation 
1.4.3.1 STAT3 – a Gene Transcription Factor to Induce Axonal Growth 
It is well known that the CNS is not capable of regenerating axons after injury. The peripheral 
nervous system (PNS) however has shown to be able to induce the regrowth of injured axons 
via the activation of an intrinsic growth program. The activation of transcription factors 
(TF’s) such as c-Jun, CREB, SMAD, Atf-3 (Raiwich and Makwana, 2007; Zou et al., 2009; 
Seiiffers et al., 2007) and in particular the signal transducer and activator of transcription 3 
(STAT3) (Qui et al., 2005; Aaronson et al., 2002), have been shown to take place after injury. 
STAT3 usually appears in the cytoplasm in an inactive state. Only the binding of cytokines 
like interleukin 6 (Il6, Zhong et al., 1994), ciliary neurotrophic factor (CNTF, Rajan et al., 
1996) or leukemia inhibitory factor (LIF, Kunisada et al., 1996) to their receptors leads to 
phosphorylation of the Janus kinase (JAK) and in turn the  phosphorylation of STAT3 and 
thus its homodimerization. This activated form now is transported to the nucleus where it 
binds to DNA-response elements which activate the transcription of specific genes (Zhong et 
al., 1994) (Figure 6). The sustained activation of STAT3 has been shown to be a key 
requirement for the timely induction of the intrinsic growth program in the dorsal root 
ganglion (DRG, Bareyre et al., 2011). Further studies implicated an important role of STAT3 
during neuronal growth initiation. For instance the nuclear accumulation and phosphorylation 
of STAT3 is correlated to the regenerative responses of the neuron after injury (Bareyre et al., 
2011). Also deletion or inhibition this TF impairs the initiation of PNS regeneration (Bareyre 
et a., 2011) or blocks the growth promoting effect after a lesion in the CNS (Qiu et al., 2005). 
Also, STAT3 overexpression as well as the blockage of its inhibitor SOCS3, can improve 
sprouting of the central DRG projections (Bareyre et al., 2011). 
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Finally, the co-deletion of SOC3 and PTEN enables robust and sustained axonal regeneration 
via concurrent activation of mTOR and STAT3 in the retinal ganglion cells (RGCs) after 
crush injury (Sun et al., 2011). 
These key findings after injury and its previously described role during the neuronal 
development, i.e. axon pathfinding, neurite outgrowth and glial cell differentiation (Dziennis 
and Alkayed, 2008, Gautron et al., 2006), give rise to STAT3 being a very good candidate to 
initiate the intrinsic growth program after SCI and thereby induce growth of newly born CST 
collaterals. 
 
 
 
 
 
Figure 6: STAT3 Signaling Pathway. After binding of several cytokines (e.g., IL-6 receptor) to 
the JAK, Jak itself gets phosphorylated and thereby initiates the phosphorylation of STAT3. After 
STAT3 is phosphorylated on a tyrosine residue by activated tyrosine kinases in receptor 
complexes, it forms homodimers and heterodimers and translocates to the nucleus. In the nucleus, 
STAT3 dimers bind to specific promoter elements of target genes and regulate gene expression 
(Modified from Huang, 2007; Re-print permission from American Association for Cancer 
Research). 
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1.4.3.2  Fibroblast Growth Factors and their Receptors: Important 
Inducers for Presynaptic Differentiation 
The family of fibroblast growth factors contains of 22 FGF’s in human and mice and its four 
corresponding receptors (FGFR1 – FGFR4) (Figure 7a). The receptors are cell surface 
receptor tyrosine kinases (RTK’s) with a transmembrane domain, an extracellular binding 
domain for the FGF’s and an intracellular domain with its tyrosine kinase activity which 
interacts with intracellular signal transduction molecules (Böttcher and Niehrs, 2005). 
Binding of the FGF ligand to its receptors leads to dimerization of the receptor (Figure 7b) 
and downstream to the activation of the intracellular pathways such as the RAS/ MAPK 
pathway (Wang et al., 1996; Kouhara et al., 1997) or the PLCɣ/Ca²+ pathway (Hall et al., 
1996; Doherty et al., 1996). Each receptor responds to only a certain subset of ligands (Zhang 
et al, 2006; Guillemot and Zimmer, 2011). The FGF10 family which also includes FGF7 and 
FGF22 binds specifically to FGF receptor 1 and 2 and has been shown to be involved in early 
synapse organization (Figure 7c, Fox et al., 2007). The importance of FGF22 for presynaptic 
differentiation during CNS development has also been shown by Umemori et al. in 2004. The 
authors purified putative target – derived presynaptic organizers from the developing mouse 
brain and identified FGF22 as the major active species. In additional experiments they could 
show that FGFR2bAP, a blocking protein which binds FGF22, inhibited presynaptic 
differentiation of mossy fibers in vitro and in vivo (Umemori et al., 2004). Also this paper 
points toward FGFR2b being the major receptor for FGF22 as experiments with the FGFR2c 
isoform do not show that effect on synapses. A couple of years later another publication could 
show even more precisely the involvement of the FGF10 family in presynaptic differentiation 
(Terauchi et al., 2010).  
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In this very nice study the authors show, that depending on which ligand binds to the receptor, 
either inhibitory (FGF7) or excitatory (FGF22) synapse formation in the CA3 region of the 
developing mouse hippocampus is induced (Figure 7d; Terauchi et al., 2010). To show this, 
they used Knock-out mice for either FGF7 or FGF22 and were able to demonstrate, that 
depending on which factor was missing, the inhibitory, GABAergic or excitatory, 
glutamatergic synapses showed deficits in clustering of synaptic vesicles (SV) in the pre-
synapse and of VGAT or VGLUT1 labeling respectively. Also analyzing the excitatory or 
inhibitory postsynaptic currents in FGF22KO or FGF7KO showed decrease in frequency, 
indicating functional consequences of the change in the vesicle pools.  
These three studies (Umemori et al, 2004; Fox et al., 2007; Terauchi et al., 2010) show the 
important role of the FGF10 family and their receptors in synaptogenesis during development 
thereby making them interesting candidates for studying their role in synapse formation 
during detour circuit formation after SCI. 
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Figure 7. The FGF family involved in presynaptic differentiation. a) Structure and 
binding specificity of the different FGF’s to the receptors. The FGF10 family (outlined 
in red) binds mainly to FGFR1 and 2. b) Binding of the ligand leads to dimerization and 
phosphorylation of the receptor and thereby to activation of the downstream pathways. 
c) Sequential expression of synaptic organizers. FGFs of the 7/10/22 subfamily act 
through FGFR2 to cluster synaptic vesicles in embryos. Additional molecules like 
Collagen a2, b2 laminins, Collagen a3 and a6 follow in the maturation process. d) 
Scheme of distinct synapse development. FGF22 induces excitatory, FGF7 inhibitory 
synapse development (Re-print permission from Elsevier for a and c; Re-print 
permission from Nature Publishing Group for b and d) 
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2.  Aims of the Thesis 
With the different studies of my thesis I am trying to gain more insight into the different 
aspects and phases of spinal cord injury induced detour circuit formation. In my thesis I will 
focus on the two phases of detour circuit formation and therefore asked the following 
questions: 
1) Which factors are important inducers of axonal outgrowth during spinal remodeling? 
In previous studies of our lab and in other studies it has been shown that STAT3 - a 
transcription factor which regulates the transcription of several growth promoting molecules 
(Zhong et al., 1994, Akira, 2000) – is important for initiation of peripheral nerves to 
regenerate (Bareyre et al., 2011) and for the initiation of axonal growth for regeneration in the 
CNS (Pernet et al., 2013). In the first aim of my thesis, I thought of investigating if STAT3 is 
also crucial for initiating the growth of the newly born CST collaterals during detour circuit 
formation. To test this, I specifically ablate STAT3 in the cells of layer V of the motorcortex 
(the origin of the fibers of the corticospinal tract in the spinal cord) and analyze if the deletion 
of STAT3 changes the pattern of axonal outgrowth of the collaterals after injury. In an 
additional set of experiments, I aim to overexpress STAT3 in CST fibers via gene therapy in 
the layer V neurons of the motorcortex. Deleting or overexpressing STAT3 in the CST allows 
us to specifically analyze the role of STAT3 in SCI induced axonal outgrowth. 
2) Which axon guidance and synaptogenesis molecules could guide growing collaterals 
and induce synapse formation during detour circuit formation? 
A lot of developmental studies have shown that for the precise growth and targeting onto 
specific neurons, certain axon guidance and synaptogenic molecules are needed (for review  
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see Kolodkin and Tessier-Lavigne, 2011 and Fox and Umemori, 2006). For instance, Netrins 
(Serafini et al., 1996), Slits (Lopez-Bendito et al., 2007) and Semaphorines (Behar et al., 
1997) have been shown during development to guide axons to their target area and once the 
axon reached its target cell, synaptic molecules such as SynCAMs (Biederer et al., 2002), 
Neuroligins (Scheiffele et al., 2000) and molecules from the Ephrin family (for review see 
Klein, 2012) are important inducers for contact formation via pre- or postsynaptic 
differentiation during development. In the second aim of my thesis, I was investigating if 
some of these developmental cues are also expressed in the adult CNS and if so, whether they 
play an important role during spinal remodeling after SCI. To answer these questions I 
perform an in situ hybridization expression profile of the cues on different types of spinal 
interneurons such as excitatory short (SPSN) and long propriospinal neurons (LPSN) 
(retrogradely labeled) or inhibitory glycinergic interneurons (transgenetically labeled) in the 
cervical spinal cord of healthy and lesioned mice. The expression profile aims at helping to 
find interesting candidates for the establishment of the detour circuit formation. 
3) Which role does the fibroblast growth factor 22 signaling play in the process of 
synapse formation during injury induced remodeling? 
Developmental studies have shown that FGF22 and its receptors are important inducers of 
excitatory presynaptic differentiation, i.e. in the cerebellum (Umemori et al., 2004), in nerve 
terminals of motorneurons (Fox et al., 2007) or in the hippocampus (Terauchi et al., 2010). In 
the third aim of my thesis I was investigating if FGF22 and its receptors are important for 
synapse formation of the newly born CST collaterals onto the LPSN in the adult CNS after 
SCI. To test this, I specifically ablate FGFR1 and FGFR2 in the hindlimb CST (genetically or 
via gene therapy Figure 8a), or analyze the impact of the deletion of FGF22 (Figure 8b) on the 
detour circuit formation after injury. 
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These different approaches to suppress FGF22 signaling allow me to study its role 
specifically in synapse formation after injury induced remodeling.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8: The different attempts of ablating FGF22 or its receptors in the adult spinal 
cord. a) Specific Knockout of FGFR1, FGFR2 or both at the same time in the axons of the 
hindlimb CST (red neuron). b) Full Knockout of FGF22 leads also to a loss of FGF22 in the 
LPSN (green neuron) of the cervical spinal cord. (Modified from Terauchi et al., 2010, Re-print 
permission from Nature Publishing Group) 
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3. Results 
The work during this doctoral thesis has resulted in two peer-reviewed publications and one 
manuscript currently submitted to Nature Neuroscience for peer-review. They are included in 
this thesis and constitute Chapter III. 
 
• Lang C, Bradley P, Jacobi A, Kerschensteiner M, Bareyre FM. (2013). STAT3 
promotes corticospinal remodeling, regeneration and functional recovery after spinal 
cord injury. EMBO Rep 2013 Oct; 14(10):931-7. 
 
• Jacobi A, Schmalz AM and Bareyre FM. (2014). Abundant Expression of Guidance 
and Synaptogenic Molecules in the Injured Spinal Cord. PLoS One 2014 Feb 
11;9(2):e88449 
 
• Jacobi A, Loy K, Schmalz AM, Hellsten M, Umemori H, Kerschensteiner M, Bareyre 
FM. (2014). FGF22 signaling regulates synapse formation during post injury 
remodeling of the spinal cord. A manuscript to be submitted. 
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STAT3 promotes corticospinal remodeling, regeneration and 
functional recovery after spinal cord injury 
 
 
Lang C, Bradley P, Jacobi A, Kerschensteiner M, Bareyre FM 
An article published in EMBO Reports (EMBO Rep 2013 Oct; 14(10):931-7) 
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Abundant Expression of Guidance and Synaptogenic Molecules in 
the Injured Spinal Cord 
 
 
Jacobi A, Schmalz AM and Bareyre FM. 
An Article published in PLoS One 2014 Feb 11;9(2):e88449 
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The remodeling of axonal circuits requires the formation of new synaptic 
contacts to enable functional recovery after injury.  Here we show that 
depletion of FGF22 or its receptors FGFR1 and FGFR2 impairs formation of 
new synapses, delays synapse maturation and impedes functional recovery in 
a mouse model of spinal cord injury. Hence, FGF22 acts as a synaptogenic 
mediator in the adult CNS and is required for efficient post-injury remodeling.  
 
  
Incomplete lesion of the spinal cord can be followed by substantial functional 
recovery in both human patients and rodent models. This recovery is mediated by the 
remodeling of spinal and supraspinal axonal circuits (Bareyre et al., 2004; Bareyre et 
al., 2005; Courtine et al., 2008; Courtine et al., 2009; Lang et al., 2011; Vander Brand 
et al., 2012; Beauparlant et al., 2013). The hindlimb corticospinal tract (CST), for 
example, responds to a thoracic transection with the de novo formation of intraspinal 
detour circuits that circumvent the lesion site and re-establish a functional connection 
between the motor cortex and the lumbar spinal cord (Bareyre et al., 2004; 
Kerschensteiner et al., 2004; Lang et al., 2011). The key step in the formation of this 
detour circuits is the establishment of new synaptic contacts between newly formed 
CST collaterals that enter the cervical gray matter and long propriospinal neurons 
that are located in the cervical cord and act as a relay to lumbar motor circuits. While 
the functional importance of this and similar detour circuits has been well established 
over the recent years (Bareyre et al., 2004; Courtine et al., 2008; Vander Brand et al., 
2012; Beauparlant et al., 2013) it is currently unclear which mechanisms regulate the 
formation of these circuits. In particular, little is known about the molecular signals 
that can induce the formation of new synapses in the injured adult CNS.  
In the developing nervous system however a number of synaptogenic molecules 
have been identified (Jessel and Sanes, 2000, Sanes and Lichtman, 2001). These 
include the family of the fibroblast growth factors and their receptors that have 
emerged as important regulators of  presynaptic differentiation (Umemori et al., 2004; 
Terauchi et al., 2010; Stevens et al., 2010; Lee and Umemori, 2013; Singh et al., 
2012). One member in particular, FGF22, is crucial for the establishment of excitatory 
synapses as shown for CA3 pyramidal cells in the developing hippocampus 
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(Terauchi et al., 2010). To investigate whether FGF22 signaling could also regulate 
synapse formation during post injury remodeling we first determined the expression 
and localization of FGF22 in the spinal cord of adult mice using in situ hybridization 
and single cell laser microdissection followed by quantitative PCR analysis (see 
Online Methods). Our results showed that FGF22 is expressed in spinal interneurons 
including a large proportion of long propriospinal neurons both constitutively as well 
as after spinal cord injury (Fig. 1a-d). To directly assess the role of spinal FGF22 
expression we performed a T8 spinal cord injury in FGF22 deficient mice (Terauchi et 
al., 2010). Deletion of FGF22 reduced the formation of CST boutons (Fig. 1e, f) as 
well as the proportion of LPSN relay neurons that are contacted (Fig. 1 g, h) at 3 
weeks after injury, while the sprouting and branching of CST collaterals was not 
affected (Supplementary Fig. 1). Deletion of FGF22 did not affect the normal 
development of mature CST projection in healthy mice (Supplementary Fig. 2). To 
better understand which receptors mediate FGF22 signaling to CST collaterals we 
first established that the two main FGF receptors, FGFR1 and FGFR2 (Umemori et 
al., 2004; Lee and Umemori, 2013) were expressed in the cortex of adult mice (Fig. 1 
i-m) and then conditionally deleted them in the forebrain by crossing floxed mouse 
strains to EMX-Cre mice (Fox et al., 2007). While deletion of the receptors did not 
affect the development of a mature CST projection pattern in healthy mice 
(Supplementary Figure 3 and 4), the deletion of either FGR1 or FGR2 reduced the 
formation of synaptic bouton on newly formed CST collaterals. A similar reduction 
was observed in double-floxed mice, in which both FGFR1 and FGFR2 were 
selectively deleted in the hindlimb motor cortex by stereotactic injection of an rAAV-
GFP-Ires- Cre (Fig.1 n,o) indicating that the effect of FGF22 on synapse formation 
requires the presence of both receptors on cortical projection neurons. Notably, 
reduced synapse formation was compensated by increased sprouting of CST 
collaterals if either FGFR1 or FGFR2 was deleted but not if both receptors were 
missing (Supplementary Figure 5) suggesting that FGF22 signaling via either 
receptor participates in the induction of compensatory CST sprouting. As a result 
only mice in which both FGFR1 and R2 were deleted showed impaired formation of 
detour circuits (Fig. 1p).  
To evaluate whether FGF22 signaling not only regulates the formation of new 
synapses but also their molecular composition (as suggested by results in the 
developing hippocampus; Terauchi et al., 2012), we evaluated the expression of an 
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early (Bassoon, Lang et al., 2012) and late (Synapsin, Lang et al., 2012) marker of 
synapse maturation in newly formed hindlimb CST collaterals at different time points 
after injury by confocal microscopy and quantitative immunohistochemical analysis. 
We observed that deletion of either FGFR1 or FGFR2 alone led to a delay in 
synapse maturation that was most obvious at 3 weeks after injury whereas complete 
deletion of FGFR signaling either by conditional depletion of both receptors or by 
depletion of FGF22 enhanced the delay and induced synapse maturation defects that 
persisted for more than 12 weeks after injury (Fig. 2).  
 Finally we wanted to understand whether delayed synapse formation and maturation 
of newly formed CST collaterals would indeed affect the spontaneous recovery of 
CST function that follows an incomplete spinal cord injury. For this we performed T8 
dorsal hemisection and followed the recovery of CST function using specific 
behavioral testing paradigms such as the “ladder rung test” (Metz and Wishaw, 2009) 
in FGF and FGFR competent control mice and in mice in which FGFR22 signaling 
was genetically interrupted by FGF22 deletion or the conditional ablation of FGFR1 
and R2 receptors. Deletion of FGF22 or co-deletion of FGFR1 and R2 in the hindlimb 
motor cortex significantly delayed functional recovery in behavioral test paradigms 
(Fig. 3). Deletion of either FGFR1 or FGFR2 alone did not alter functional recovery 
likely due to the compensatory increase in CST sprouting that prevented deficits in 
detour circuit formation (Supplementary Figure 6).  
Together, the targeted deletion of FGF22 and its receptors FGFR1 and FGFR2 thus 
identify an important contribution of FGF22-FGFR signaling to the formation new 
CST boutons, the maturation of synaptic contacts and the recovery of locomotor 
function after spinal cord injury. These results establish that FGF22 acts as a 
synaptogenic mediator in the adult nervous system and a crucial regulator of 
synapse formation and maturation during post-injury remodeling in the CNS.   
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FIGURE LEGENDS  
Figure 1. Deletion of FGF22 or its receptors impairs synapse formation and circuit 
remodeling after spinal cord injury. (a) In situ hybridization of FGF22 mRNA in the 
spinal cord of FGF22 competent and FGF22 deficient mice (right panel). (b) In situ 
hybridization showing localization of FGF22 signal in LPSN retrogradely labeled from 
T12 (LPSN: green; FGF22: red; Neurotrace 435: Blue). (c) Quantification of the 
percentage of LPSN showing FGF22 in situ signal in unlesioned mice (“Ctrl”) and at 3 
(“3w”) and 12 (“12w”) weeks after injury (n=5 in all groups). (d) Images illustrating 
single cell laser microdissection to perform quantitative single cell PCR. Top panel 
shows three long propriospinal neurons (LPSN) retrogradely labeled from T12 with 
Texas Red. Bottom panel shows the two remaining LPSN after one (asterisk) has 
been microdissected. (e) Quantification of single cell PCR analysis of FGF22 
expression in LPSN in unlesioned mice (“Ctrl”) and at 3 (“3w”) and 12 (“12w”) weeks 
after injury (n=5 in all groups). (f) Confocal images showing synaptic boutons on 
newly formed cervical hindlimb CST collateral 3 weeks following spinal cord injury 
(Left panel: FGF22 competent mouse; Right panel: FGF22 deficient mouse). (g) 
Quantification of boutons density on newly formed cervical hindlimb CST collaterals 
in FGF22 competent and deficient mice (n=8 per group). (h) Confocal image of 
putative synaptic contacts between CST collaterals (green) and LPSN (red). (i) 
Quantification of the percentage of LPSN contacted by CST collaterals in FGF22 
competent and deficient mice (n=8 per group). (j, k) In situ hybridization of FGFR1 
(top) and FGFR2 (bottom) mRNA in FGFR competent animals (j) and forebrain 
FGFR1 (k, top panel) and FGFR2 (k, bottom panel) deficient mice. (l) Retrograde 
labeling of CST neurons with Texas Red® (green) show that CST neurons express 
FGFR1 and FGFR2 (insets in k top and bottom are two-fold magnification of boxed 
areas). (m) Quantification of the percentage of CST neurons in layer V of the cortex 
expressing FGFR1 and FGFR2 (n=3 per group). (n) Quantification of the intensity of 
the in situ signal for FGFR1 in FGFR2 deficient mice and FGFR2 in FGFR1 deficient 
mice (n=3 per group). (o)  Confocal images showing synaptic boutons on newly 
formed cervical hindlimb CST collateral 3 weeks following spinal cord injury (left 
panel: FGFR competent animal; Right panels: forebrain FGFR1, FGFR2 and 
FGFR1R2 deficient mice). (p) Quantification of the bouton density on newly formed 
cervical hindlimb CST collaterals in FGFR competent and forebrain FGFR deficient 
animals (n=8 for all group but FGFR1R2 co-deletion in which n=7). (q) Quantification 
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of the percentage of LPSN contacted by CST collaterals in FGFR competent and 
forebrain FGFR deficient mice (n=8 for all group but FGFR1R2 co-deletion in which 
n=7). Scale bars equal 200µm in a (10µm in inset); 20µm in b, 75µm in c, 20µm in f, 
30µm in h, 200µm in j and k, 100µm in l (20µm in insets), 20µm in o. p value *p<0,05; 
**p value<0,01; *** p value< 0,001. Unpaired t-tests were used for two–column 
comparisons, ANOVA followed by Tukey tests were used in case of multiple group 
comparison. 
 
Figure 2: Deletion of FGF22 or its receptors delays synapse maturation following 
spinal cord injury. (a) Confocal image of Bassoon immune reactivity (red) in synaptic 
contacts between a CST collateral (green) and a LPSN (blue). Right images are 
magnification (two-fold) of the area boxed on the left.  (b) Quantification of the 
percentage of boutons on cervical hindlimb CST collaterals that are immunoreactive 
for Bassoon at 3 weeks (left panel) and 12 weeks (right panel) after spinal cord injury 
in FGF22 deficient and forebrain FGFR1, FGFR2 and FGFR1R2 deficient mice 
compared to FGF22 and FGFR competent mice (“Control”). (c) Confocal image of 
Synapsin immune reactivity (red) in synaptic contacts between a CST collateral 
(green) and a LPSN (blue). Right images are magnification (two-fold) of the area 
boxed on the left. Confocal image of a synaptic contact between CST collateral 
(green), a propriospinal neuron (blue). (d) Quantification of the percentage of boutons 
on cervical hindlimb CST collaterals that are immunoreactive for Synapsin at 3 weeks 
(left panel) and 12 weeks (right panel) after spinal cord injury in FGF22 deficient and 
forebrain FGFR1, FGFR2 and FGFR1R2 deficient mice compared to FGF22 and 
FGFR competent mice (“Control”). Scale bars equal 20µm in a; and 20µm in b. T-test 
was used for paired comparisons, ANOVA followed by Tukey tests were used in case 
of multiple group comparison. 
 
Figure 3: Genetic disruption of FGF22 signaling impedes functional recovery 
following spinal cord injury. (a) Image of a spinal cord injured animal performing the 
ladder rung test that assesses recovery of CST function. (b) Quantification of the 
functional recovery in the ladder rung test (irregular walk, upper panel; regular walk, 
lower panel) in control (white bars), FGF22 deficient (red bars) and forebrain FGFR1 
89 
 
R2 deficient (blue bars) mice.  Repetitive ANOVA followed by Tukey tests were used 
for multiple group comparison. 
 
 
ONLINE METHODS 
Animals: Adult mice from 6 to 12 weeks of age were used in the study. FGFR1fl/fl 
and FGFR2fl/fl mice (Yu et al., 2003; Pirvola et al., 2002), in which the FGFR1 or 
FGFR2 gene is flanked by loxed P sites have been used to study the importance of 
FGFR1 and FGFR2 to post-injury remodeling. Littermates have been used as 
controls. To delete FGFR1 or FGFR2specifically in the CST, we have crossed 
FGFR1fl/fl and FGFR2fl/fl mice to Emx1-Cre mice (Gorski et al., 2002; Bareyre et al., 
2004) which trigger Cre expression in the forebrain as of embryonic day 10. For co-
deletion of the two receptors in the CST, we did crossed FGFR1fl/fl and FGFR2fl/fl 
until obtaining double floxed offsprings. Then we injected adeno-associated viruses 
expressing the cre recombinase in layer V of the hindlimb motor cortex.  To identify 
the role of FGF22 in the process of detour circuit formation after injury we used 
FGF22 knock-out mice (Terauchi et al., 2010). Normal wildtype C57Bl6j mice 
(Janvier, France) were used as control group for the FGF22 KO mice.  All animal 
procedures were performed according to institutional guidelines and were approved 
by the Regierung von Oberbayern. 
 
Generation and production of AAV vectors: pAAV- GFP-Ires-Cre was created by 
inserting an Ires sequence (from pIres2-DsRed2 (BD Bioscience) at the HincII site. 
The Cre coding sequence was excised from PBS185 (kind gift of Thomas Hughes, 
Montana State University) and inserted upstream to the Ires sequence at the site. 
Green Fluorescent protein (GFP) was excised from pEGFP-N1 and inserted 
downstream to the Ires sequence at. The Control pAAV-CMV-Ires2-GFP used was a 
kind gift of Hildegard Büning (Medical University of Cologne). pAAV-CMV-FGF22-
Ires-GFP was created by excising FGF22 coding sequence from APtag5 (H. 
Umemori, Michigan University) with NheI, XhoI and ligating it into the pAAV –CMV- 
Ires-hrGFP vector (Stratagene) at the HincII site. The original pAAV-Ires-hrGFP 
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(Stratagene) for the above cloning was used as control. Production was done as 
indicated.  
Genomic titers were as follows: 
pAAV-GFP-Ires2-Cre, 1,2 x 10^12 genomes copies /ml 
pAAV- Ires2-GFP, 2,4 x 10^12 genomes copies/ml 
pAAV-FGF22-Ires-hrGFP, 2,06x10^13 genome copies/ml;  
Control pAAV-Ires-hrGFP, 6,55x10^13 genome copies/ml;  
 
Surgical procedures 
Midthoracic dorsal hemisection. Mice were anesthetized with a subcutaneous 
injection of ketamin/xylazine (ketamine 100 mg/kg, xylazine 13 mg/kg). After a 
laminectomy to expose the dorsal spinal cord at thoracic level 8 (T8), a midthoracic 
dorsal hemisection, which results in a transection of the main dorsal and minor 
dorso-lateral CST component, was performed with fine iridectomy scissors  as 
previously described (Lang et al., 2011; Lang et al., 2012). Prior to and after surgery 
animals were kept on a heating pad (38°C) until fully awake and treated with 
Metacam (Boehringer Ingelheim) twice per day for 48 hours.  
 
Deletion of FGFR1 or FGFR2 and co-deletion of FGFR1 R2: To ablate FGFR1 or 
FGFR2 specifically in the CST, FGFR1fl/fl or FGFR2fl/fl were crossed to EMX1-Cre 
mice (Bareyre et al., 2005). For co-deletion of FGFR2 and FGFR1, FGFR1fl/fl were 
crossed to FGFR2fl/fl until obtaining homozygote double-floxed mice. Then, 0,7μl of 
rAAV-GFP-Ires2-Cre or control rAAV-Ires2-GFP were concentration-matched (to  0.6 
x10^12 genomes copies /ml) and then pressure-injected 4 days prior to the lesion 
into the hindlimb motor cortex using a finely pulled glass micropipette (coordinates 
from bregma: -1.3mm caudal; 1.0mm lateral; 0.6mm depth).The micropipette 
remained in place for 3 minutes following the injection. This produced deletion of 
FGFR1R2 in the motor cortex and labeled the CST in these co-deleted mice.  In 
order to verify that the virus remained confined to the hindlimb motor cortex and did 
not spread to the forelimb area, we amplified the GFP signal with an anti – GFP 
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antibody (rabbit polyclonal anti GFP; Invitrogen A11122), cut consecutive 50µm thick 
sections of the entire brain of all mice in order and determined the spread of the 
labeling of GFP labeled cells in layer V (Suppl. Fig. 7 a,b). Mice in which the labeling 
reached the forelimb motorcortex (coordinate from bregma: +0.5mm caudal) were 
excluded from the evaluation. To confirm that genetic FGFR deletion was similar to 
viral FGFR deletion, we virally deleted FGFR2 in the hindlimb cortex by injecting 
0,7µl of AAV-GFP-Ires-Cre at the following coordinates (bregma: -1.3mm caudal; 
1.0mm lateral; 0.6mm depth). No differences in boutons number, branchpoints and 
exiting CST collaterals could be seen between the genetic (see Fig. 1p,q) and the 
viral (Suppl. Fig. 8) FGFR2 deletion. 
 
Labeling of the hindlimb CST (hCST) fibers: The hindlimb CST of FGFR1fl/fl or 
FGFR2 fl/fl crossed with the EMX-Cre mice (n= 8 per group) was traced by pressure 
injecting 1,5µl of a 10% (in 0.1M PB) solution of biotinylated dextran amine (BDA, 10 
000 MW, Life Technologies) into the hindlimb motor cortex using a finely pulled glass 
micropipette two weeks prior to sacrifice using the following coordinates: −1.3 mm 
posterior to bregma, 1 mm lateral to bregma, 0.6mm depth. The micropipette 
remained in place 3 minutes following the injection. 
Labeling of long propriospinal neurons: Long propriospinal neurons were 
retrogradely labeled by pressure injections of 0.5µl of 2.5% TexasRed (dextran, 
fluorescein, 3000 MW, Life technologies) or 0.25µl of 2% Fluoro–GoldTM (Santa 
Cruz Biotechnology; sc-358883). Briefly, a laminectomy was performed at  thoracic 
level 12 as previously described (Lang et al., 2013) and the 0.5µl of 2.5% TexasRed  
or the 0.25µl of 2% Fluoro-GoldTM was injected into each side of the spinal cord 
using a thin glass capillary (coordinates from central vein: ± 0.6mm; depth: 0.9mm). 
The capillary was maintained in place for 3 minutes following the injection. Mice were 
sacrificed 3 or 12 weeks after dorsal hemisection. 
Tissue processing and histological analysis: Mice were deeply anesthetized with 
isoflurane and perfused transcardialy with saline solution followed by 4% 
paraformaldehyde (PFA) in 0.1M phosphate buffer (PBS). Brains and spinal cords 
were dissected and post-fixed overnight in PFA. The tissue was then cryoprotected in 
30% sucrose (Sigma) for at least 3 days. Coronal sections (50μm thick) were cut on 
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a cryostat. To visualize CST collaterals, BDA detection was performed as follows: 
Sections were incubated in ABC complex (Vector Laboratories) overnight at 4°C. 
After a 20 min tyramide amplification (Biotin-XX, TSA Kit #21, Life technologies) 
sections were incubated overnight with Streptravidin conjugated to FITC 488 (1:500, 
Life technologies). To visualize CST collaterals of the rAAV injected mice, an anti –
GFP staining was performed to amplify the GFP signal. Anti – GFP antibody (dilution 
1:500; Life Technologies A11122) diluted in PBS containing 0.1% Triton X-100 and 
2.5% goat serum (Life Technologies) was thus applied and incubated over night at 
4°C. On day 2, the corresponding secondary antibody was applied for at least 4 
hours (goat anti rabbit conjugated with Alexa 488).  
For synapse characterization, 20µm thick sections were cut and blocked for 1 hour 
with 5% GS (Life technologies) and 0.3% Triton X-100 diluted in 1 x PBS in which the 
hCST was labeled either with BDA or with the rAAV-CMV-GFP-Ires2-Cre. Sections 
were incubated with ABC (Vector Laboratories) and a primary polyclonal antibody 
reactive against synapsin I (Millipore AB1543; dilution 1:500) or a primary mouse 
monoclonal antibody reactive against bassoon (ENZO Life Science SAP7F407, 
dilution 1:200) in Tris buffer containing 0.3% Triton X-100 (Sigma) and 2.5% goat 
serum (Invitrogen) overnight at 4°C. The following day, after a 20 min tyramide 
amplification (Biotin-XX, TSA Kit #21, Invitrogen) to detect BDA, sections were then 
incubated together with Streptavidin-FITC 488 (1:500, Life technologies) and the 
appropriate secondary antibodies for the synaptic markers (donkey anti rabbit 
conjugated with Alexa Fluor 647 or goat anti rabbit conjugated with Alexa Fluor 635) 
incubated over night at 4°C. For rAAV-injected animals (FGFR1R2 co-deletion), the 
sections were first incubated with an anti – GFP antibody (see above) to amplify the 
GFP signal (Invitrogen, A11122) together with the primary antibodies against 
synapsin I or bassoon (concentrations as above) in 2.5% GS and 0.1% Triton X-100 
in 1 x PBS over night at 4°C. On the next day the appropriate secondary antibodies 
for the GFP labeling (goat anti rabbit conjugated with Alexa Flour 488) and for 
synapse staining (donkey anti rabbit conjugated with Alexa Fluor 647 or goat anti 
rabbit conjugated with Alexa Fluor 635) were applied over night at 4°C. The 
counterstaining was performed with NeuroTrace 435 (Invitrogen) and sections were 
mounted in Vectashield (Vector Laboratories).  
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Quantification of synaptic markers: To determine the percentage of boutons that 
express the synaptic markers Synapsin I and Bassoon image stacks of about 20 
sections spanning the C3 to C5 area of the spinal cord (20µm thickness, with every 
5th section taken) were acquired with an Olympus FV1000 confocal microscope 
equipped with standard filter sets and a 660 (NA 1.45) oil immersion objective. Image 
stacks obtained with confocal microscopy were processed using ImageJ software to 
generate maximum intensity projections. On those, the percentage of Synapsin I or 
Bassoon positive boutons were determined by counting the number of Synapsin I or 
Bassoon positive boutons upon the following criteria’s: A bouton was defined as a 
varicosity along the newly born collateral in the cervical spinal cord.  Therefore this 
varicosity on the collateral is clearly distinguishable by its thickness from the thin arm 
of the collateral itself. To assess co-labeling of the boutons we used the following 
evaluation criteria: A bouton was considered Synapsin I or Bassoon positive when its 
contour was clearly overlaid with the synapse staining and did not extend beyond it. 
The number of boutons positive for Synapsin I or Bassoon was determined and 
expressed as a percentage of all boutons on the collaterals counted in the cervical 
spinal cord. A minimum of 100 boutons was counted. All quantifications were 
performed by an observer blinded with respect to injury status and treatment. 
Quantification of CST remodeling: To evaluate axonal remodeling following a 
midthoracic dorsal hemisection, traced CST collaterals entering the grey matter at 
cervical levels C4 were counted on 30 consecutive coronal sections per animal using 
a light microscope (Olympus IX471) with a x40/0.65 air objective. To correct for 
differences in inter-animal tracing efficiency, the number of collaterals was divided by 
the number of traced fibers in the main CST tract and expressed as the ratio of 
collaterals per main CST fiber (Bareyre et al., 2004). All quantifications were 
performed by an observer blinded with respect to injury status and treatment. 
Quantification of contacts onto LPSN: For quantifying the number of contacts 
formed onto LSPN a total amount of 30 sections was evaluated using a fluorescent 
microscope (Olympus IX471) with a x40/0.65 air objective. Collaterals were 
visualized as mentioned above (tyramide amplification or GFP amplification), the total 
number of LPSN labeled was counted and the total number of contacts onto those 
was examined. The number of LPSN was expressed as a ratio of all LPSN contacted 
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by collaterals over the total number of all LPSN. All quantifications were performed 
by an observer blinded with respect to injury status and treatment. 
Quantification of the length of the collaterals: To determine the length of the 
collaterals 10 sections spanning the C3 to C5 area of the spinal cord (50µm 
thickness, sections randomly taken) were acquired with an Olympus FV1000 
confocal microscope equipped with standard filter sets and a 660 (NA 1.45) oil 
immersion objective. Image stacks obtained with confocal microscopy were 
processed using ImageJ software to generate maximum intensity projections. The 
lengths of all collaterals in those sections were measured with the help of the 
measurement tool of ImageJ and a mean of the collaterals length per animal was 
acquired. All quantifications were performed by an observer blinded with respect to 
injury status and treatment.  
Cortical neuronal density: To determine whether genetic deletion of FGFR1 or 
FGFR2 at embryonic day 10 or full deletion of FGF22 alters cortical lamination and 
cortical neuronal density, we cut 50µm brain sections and performed NeuN 
immunohistochemistry (Gt anti-NeuN, Millipore, dilution 1:500, 4°C overnight). 
Counterstaining was performed with Neurotrace500. The density of cells in layer V of 
the motorcortex and sensory – motorcortex was quantified by counting the number of 
NeuN positive cells in every third section all through the hindlimb cortex for a total of 
10 sections per animal. All quantifications were performed by an observer blinded 
with respect to injury status and treatment. 
Lesion volume and Regeneration at lesion site: We verified the extent of the 
spinal cord lesion in all animals, by performing analysis of lesion volume. Lesion 
volume was assessed on spinal cord longitudinal 50µm sections spanning the entire 
lesion extent at thoracic level. Following staining with a fluorescent Nissl dye (NT435, 
LifeTechnologies N-21479, dilution 1:500) the sections were scanned using an 
Olympus IX71 microscope. Images were then processed with ImageJ and the lesion 
area, including both the cavity and surrounding damaged tissue, was outlined. To 
quantify the lesion volume, the measured lesion area of each section was multiplied 
by the section thickness (50μm) and the results of all consecutive sections spanning 
the entire lesion extension were summed up for each animal to provide a final 
estimation of the total lesion volume (Suppl. Figure 9a).  
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To determine the effect of deletion of FGF22 on the growth of CST fibers after a 
midthoracic dorsal hemisection, we analyzed consecutive longitudinal sections of the 
midthoracic spinal cord. Image stacks were recorded on Olympus IX71 microscope. 
The number of BDA-labeled growing fibers in the dorsal funiculus that intersected 
with a dorso-ventral lines positioned every 100μm distal from the lesion site was 
counted. The lesion site was identified visually and level 0 was positioned at the end 
of the retracting non growing fibers. The total number of growing fibers counted on 4-
5 consecutive longitudinal 50µm thick sections was then normalized to the number of 
fibers in the main CST tract (obtained from the dorsal funiculus at cervical C5 level) 
and divided by the number of sections evaluated. The value obtained for a given 
distance is the number of CST fibers per labeled CST axons per section, the “fiber 
number index”. To exclude a contribution from spared fibers, only fibers emerging 
from the dorsal main CST and extending in the dorsal funiculus were counted (Suppl. 
Figure 9b). 
In situ Hybridization: Spinal cord tissue (cervical region C3-C5, 20µm thick) and 
brain tissue (Bregma -1.06 till -1.70, 30µm thick) were sectioned coronally using the 
cryostat (Leica CM1850) and processed as described previously (Jacobi et al., 
2014). Briefly, all steps very carried out with DEPC treated solutions to prevent 
degradation of target RNAs. Sections were washed in 2X SSC (from 20X stock 
solution containing 3M NaCl and 0,3M Na Citrate) and before the prehybridization 
step, the sections were incubated in a 1:1 mixture of 2X SSC and hybridization buffer 
(50% Formamide, 5X SSC, 5X Denhardt’s solution (Sigma-Aldrich D2532), 250μg/ml 
yeast tRNA, 500μg/ml salmon sperm DNA) for 15min at RT. Sections were then 
incubated for 1hr in hybridization buffer at the appropriate (pre-) hybridization 
temperature (65°C). For hybridization, the probe (200-400ng/ml in hybridization 
buffer) was heated for 10min at 80°C, applied to the tissue and incubated overnight 
in an oven at 65°C. Sections were then rinsed at RT in 2X SSC and washed in 
decreasing concentration of SSC (2X to 0.1X SSC at hybridization temperature) 
before applying an alkaline-phosphatase-conjugated sheep anti-digoxigenin 
antibody, Fab fragments (1:2000; Roche Diagnostics) in blocking buffer overnight at 
4°C. Alkaline phosphatase activity was detected using nitroblue tetrazolium chloride 
(337.5mg/ml) and 5-Bromo-4-chloro-3-indolyl phosphate (175mg/ml) (Carl Roth). The 
sections were washed in ddH2O after the staining procedure. The fluorescent Nissl 
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stain Neurotrace 435 was applied for 2h at RT; the sections were washed and 
mounted with Gel Mount (Sigma Aldrich). 
Lasermicrodisection: Total RNA was isolated from LPSN in unlesioned animals 
and 3 weeks after lesion (n = 2 per timepoint). For this purpose 20µm thick fresh 
frozen coronal sections (C3-C5) were collected on Membrane Slides 1.0 PET (Zeiss). 
Sections were covered with n-propanol to prevent drying and to inhibit RNase 
activity, and immediately transferred to a PALM Microbeam-Z microscope. LPSN 
retrogradely labeled with TexasRed and located between layers 6 to 9 in C4 were 
marked electronically. After evaporation of the n-propanol, a total of 10 marked 
neurons were microdissected and laser pressure catapulted into a reaction tube 
(AdhesiveCap 200 clear PCR tubes, Zeiss) and directly put on dry ice. After 
microdissection, it was visually verified that all neurons were actually captured. For 
single cell, QPCR, we used the kit Lifetechnologies. Shortly, one single cell is lysed 
in 10µl Single Cell Lysis/Dnase I solution à 5 min RT. 1 μL of Stop Solution is added 
to lysis reaction -à2min RT and 4.5 μL of RT Mix is added à RT:  Incubate for 10 min 
at 25 °C. Incubation is carried for 60 min at 42 °C and for 5 min at 85 °C. Then 11 μL 
of PreAmp Mix with Primers is added ( FGF22 Forward primer 5'- ACT TTT TCC 
TGC GTG TGG AC -3', FGF22 Reverse primer 5'- TCA TGG CCA CAT AGA AGC 
CT -3'; GapDH Forward primer 5’-TCA ACG ACC CCT TCA TTG-3’, GapDH Reverse 
primer 5’-ATG CAG GGA TGA TGT TCT G-3’). PreAmplification reaction is as 
follows: 95 °C 10 min; 14 cycles: 95 °C for 15 sec, 56 °C for 2 min,  60 °C for 2 min. 
Probes are diluted 1:10 in H2O. 5µl of the probe is used for qPCR in a total volume of 
20µl. Then we use the 2xSsoAdvanced Universal SYBR Green Supermix (BioRad) 
for QPCR with the following protocol: 95°C 3min; 95°C 10sec; 56°C 10sec; (39 
repeats).the melting curve is carried with 65°C to 95°C increments. 
Behavioral Analysis: The following behavioral tests were used to assess locomotor 
recovery after spinal cord injury.  
BMS: We used the Basso mouse scale to assess overall recovery of hindlimb 
locomotion after a spinal lesion. Following the ranking system previously described 
(Basso et al., 2006) mice were given scores from 0-9, with a score of 0 indicating no 
ankle movement and a score of 9 indicating frequent or consistent plantar stepping, 
mostly coordinated stepping, paws parallel at initial contact and lift off, normal trunk 
stability and tail consistently up. For evaluation, the mice (n = 12 per group) were 
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placed in an open field for 4 min and assessed by two observers blinded to the 
genotype of the mice. Mice were assessed before and 2, 7, 14 and 21 days after 
lesion. For overexpression experiments the mice were assessed until 8 weeks after 
lesion. 
Ladder Rung: For more refined  assessment of the CST function following spinal 
cord injury, we used the ladder rung test, or grid walk, which has been described 
previously (Metz and Whishaw, 2009).  Animals were scored for their ability to cross 
accurately a 1 m long horizontal metal-rung runway with varying gaps of 1–2 cm 
between the rungs. All animals underwent a couple of familiarization sessions with 
the apparatus prior to pre-operative baseline testing. Following familiarization, 
sessions were videotaped and scored to determine baseline performance. Pre-
operative score as well as post-operative performance on day 7, 14 and 21 post 
injury, and for the long term analysis of the mice were both receptors have been 
ablated (FGFR1fl/fl ;FGFR2fl/fl) at 8, 10 and 12 weeks after lesion, were collected. A 
hindlimb foot error was defined as a complete miss or slip from the rung at the 
moment of the placement of the paw onto the rung. Baseline and post-operative 
testing sessions consisted of 3 runway crossings. The total number of errors and 
steps by the hindlimbs in each session was counted.  
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SUPPLEMENTARY FIGURES and LEGENDS 
 
 
 
 
 
 
Supplementary Figure 1. FGF22 deletion does not change CST sprouting and CST 
branching following spinal cord injury. (a) Confocal images of exiting hindlimb CST 
collaterals in the cervical cord 3 weeks following T8 hemisection in FGF22 competent (left 
panel) and FGF22 deficient (right panel) mice. (b) Quantification of the number of exiting 
CST collaterals and of the number of hindlimb CST collateral branch points 3 weeks 
following T8 hemisection in FGF22 competent and deficient animals (n=8 per group; 
compared using unpaired t-test) . Scale bar in a (both panels): 40 µm.  
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Supplementary Figure 2. Normal hindlimb CST maturation is not altered in forebrain 
FGF22 deficient mice. (a) Quantification of the number of boutons, (b) branchpoints and (c) 
of exiting CST collaterals in FGF22 competent and deficient mice (n=6 per group; compared 
using unpaired t-test). 
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Supplementary Figure 3. Normal hindlimb CST maturation is not altered in forebrain 
FGFR1 deficient mice. (a,b) Confocal images of the cortex of FGFR1 competent (a) and 
forebrain FGFR1 deficient (b) mice. (c) Quantification of the number of neurons in layer V of 
the cortex in FGFR1 competent and forebrain FGFR1 deficient mice (n=3 per group; 
compared using unpaired t-test).  (d-f) Quantification of the number of boutons (d) and 
branchpoints (e) per µm hindlimb CST collateral and the number of emerging hindlimb CST 
collaterals (f) in FGFR1 competent and forebrain FGFR1 deficient mice (n=6 per group; 
compared using unpaired t-test). Scale bar in a, b: 100 µm. 
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Supplementary Figure 4. Normal hindlimb CST maturation is not altered in forebrain 
FGFR2 deficient mice. (a,b) Confocal images of the cortex of FGFR2 competent (a) and 
forebrain FGFR2 deficient (b) mice. (c) Quantification of the number of neurons in layer V of 
the cortex in FGFR2 competent and deficient mice (n=3 per group; compared using unpaired 
t-test).  (d-f) Quantification of the number of boutons (d) and branchpoints (e) per µm 
hindlimb CST collateral and the number of emerging hindlimb CST collaterals (f) in FGFR2 
competent and forebrain FGFR2 deficient mice (n=6 per group; compared using unpaired t-
test). Scale bar in a, b: 100 µm. 
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Supplementary Figure 5. Deletion of either FGFR1 or FGFR2 but not deletion of both 
increases CST sprouting following spinal cord injury. (a) Confocal images of exiting CST 
collaterals in the cervical cord 3 weeks following T8 hemisection in FGFR competent (left 
panel) and forebrain FGFR1, FGFR2, FGFR1R2 deficient (right panels) mice. (b) 
Quantification of the number of exiting CST collaterals and of the number of CST collateral 
branch points 3 weeks following T8 hemisection in FGFR competent and forebrain FGFR 
deficient animals (n=8 per group except for FGFR1R2 deficient group in which n=7; 
compared using an ANOVA followed by Tukey test for the experiment with the single FGFR 
KO and with an unpaired t-test for the experiment using the double FGFR KO, * P <0,05). 
Scale bar in a: 40 µm.  
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Supplementary Figure 6. Deletion of either FGFR1 or FGFR2 does not impair 
functional recovery after spinal cord injury. (a) Quantification of functional recovery in 
the ladder rung test (irregular walk) in control (white bars) and conditional FGFR1 (dark blue 
bars) or FGFR2 (green bars) deficient mice (n=8 per group; compared with a repeated 
ANOVA followed by post-hoc test). (b) Quantification of functional recovery in the ladder 
rung test (regular walk) in control (white bars) and conditional FGFR1 (dark blue bars) or 
FGFR2 (green bars) deficient mice (n=8 per group; compared with a repeated ANOVA 
followed by post-hoc test). 
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Supplementary Figure 7. Stereotactic injection of AAVs allows selective targeting of the 
hindlimb motor cortex. (a) Confocal image of the hindlimb motor cortex 3 weeks following 
injection of rAAV-GFP-Ires-Cre illustrating the presence of many transduced neurons (green)  
in layer V of the cortex (blue, counterstaining with Neurotrace 435). (b) No transduced 
neurons (green) are seen in the forelimb motor cortex of the same animals.  Scale bar in a, b: 
150 µm.  
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Supplementary Figure 8. Genetic and viral deletion of FGFR2 has similar effects on 
post-injury remodeling. (a) Confocal images of exiting hindlimb CST collaterals in the 
cervical grey matter 3 weeks following spinal cord injury in FGFR2 floxed mice after 
injection of  either rAAV-GFP (left panel) or rAAV-GFP-ires-Cre (right panel) in the 
hindlimb motor cortex. (b) Quantification of the number of exiting hindlimb CST collaterals 3 
weeks following spinal cord injury in FGFR2 floxed mice after injection of  either rAAV-
GFP or  rAAV-GFP-ires-Cre in the hindlimb motor cortex.  (n=8 per group; compared using 
unpaired t-test, * P value<0,05). The amplitude of the sprouting should be compared to Suppl. 
Fig. 5 when the deletion is performed by crossing FGF22fl/fl mice with EMX-Cre mice. (c) 
Confocal images of boutons on hindlimb CST collateral in FGFR2 floxed mice after injection 
of either rAAV-GFP (upper panel) or rAAV-GFP-ires-Cre (lower panel) in the hindlimb 
motor cortex. (d-f) Quantification of the number of boutons (d), branchpoints (e) per 
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hindlimb CST collateral as well as the percentage of contacted LPSN (f) 3 weeks after injury 
in FGFR2 floxed mice after injection of either rAAV-GFP or rAAV-GFP-Ires-Cre in the 
hindlimb motor cortex (n=8 per group, compared using unpaired t-test, * P value<0,05). 
Again the changes are similar to those obtained by crossing FGF22fl/fl mice with EMX-Cre 
mice (See Fig. 1). Scale bar in a, 40 µm; in c: 15 µm. 
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Supplementary Figure 9. Lesion volume and fiber number index of regenerative fibers 
in FGF22 KO mice following spinal cord injury. (a) Confocal picture (left panel) of a 
representative longitudinal section of spinal cord around T8 showing the extent of lesion size 
using NT435. Dash lines outline the lesion area. Quantification of lesion area (µm3/ right 
panel) in FGF22 KO and control mice. (b) Fiber number index of regenerative fibers in 
FGF22 KO and control mice. Scale bar in a equals 250µm. Data were analyzed with student t-
test in (a) and a repeated ANOVA followed by post-hoc test in (b).  
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4. Discussion 
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The process of detour circuit formation after spinal cord injury is subdivided into different 
phases starting with (i) the growth of new CST collaterals, (ii) the navigation of those de novo 
collaterals toward their target area and (iii) the formation and refinement of synapses onto 
appropriate relay neurons (LPSN). My thesis was aiming at identifying some of the molecular 
mechanisms which govern these individual phases of post-injury axonal remodeling and the 
findings obtained during this time will be discussed in this chapter.      
 
4.1 Molecular modulation of post-injury outgrowth of new CST 
collaterals.  
The first aim of my thesis was the identification and manipulation of molecules that could 
influence axonal outgrowth during detour circuit formation following spinal cord injury. The 
work performed during this thesis has allowed the identification of a transcription factor 
STAT3 as a key regulator of axonal outgrowth following spinal cord injury. In the next 
paragraphs, I will discuss how STAT3 can induce sprouting of lesioned and unlesioned axons. 
 
 
4.1.1 Activation of Intrinsic Growth Program: the Example of STAT3  
CNS neurons axotomy can lead to the activation of the intrinsic growth program (Smith et al., 
2011). However this process is thought to be very transient because of a simultaneous 
activation of inhibitory growth factors (Sun and He, 2010). Accordingly, we show a transient 
expression of STAT3 in cortical projection neurons after injury which is back to baseline 
levels one week after the injury (Lang et al., 2013). This could be due to a negative feedback 
loop with the  
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upregulation of SOCS3 upon STAT3 activation. As SOCS3 is a strong inhibitor of STAT3, 
this could lead to the quick down regulation of STAT3 following CNS injury (Crocker et al., 
2008; Smith et al., 2009). In the CNS, the negative feedback loop could be regulated not only 
by SOCS3 but also by other factors. For example, a study in which the JAK-STAT pathway is 
inhibited via the infusion of a JAK2 kinase inhibitor (AG490, Qui et al., 2005), shows a 
significant reduction of dorsal column axonal regeneration after a pre-conditioning sciatic 
nerve transection. Similarly, genetically ablating the IL-6 pathway, in IL-6 deficient mice, 
leads to a failure in the regeneration processes after a conditioning lesion in the dorsal column 
neurons (Cafferty et al., 2001 and 2004). The inability of the injured neurons to regenerate in 
the CNS therefore might be due to the multi-level activation of feed-back loops triggering a 
failure of the timed upregulation of STAT3.Various studies could show that genetic deletion 
of SOCS3 is able to lead to sustained activation of STAT3 and thereby could promote axonal 
outgrowth and regeneration after a CNS lesion (Smith et al., 2009; Sun et al., 2011).  
 
The results also show that the deletion of STAT3 in cortical projection neurons does not 
impair normal post-injury axonal sprouting and spinal remodeling after spinal cord injury 
(Lang et al., 2013). Indeed, the ability of the corticospinal tract to sprout spontaneously in the 
absence of STAT3 after injury (Lang et al., 2013), as well as the ability of the DRG neurons 
to induce the growth program albeit in a delayed fashion following PNS lesion (Bareyre et al. 
2011), indicate that other growth factors can activate growth promoting pathways after injury.  
What are those factors that can initiate growth in the absence of STAT3 and may act as a 
backup system in case of absence of STAT3? 
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The intrinsic growth program has been in the focus of various studies in the last years and the 
identification of several regulators such as the members of the PTEN/ mTOR pathway (Park 
et al., 2008; Liu et al., 2010) has emerged. Liu et al., were able to show that the deletion of 
PTEN, a negative regulator for mTOR, leads to increased sprouting of CST neurons after SCI. 
Down regulation of PTEN also leads to the activation of Akt pathway (Park et al., 2010; 
Hassan et al., 2013) which in turn is known to be associated with enhanced neurite outgrowth 
in the DRG and in perinatal cortical neurons (Markus et al., 2002; Ozdinler and Macklis 
2006). Other potential candidates could be the cyclic AMP (cAMP) pathway and its 
downstream mediators (Qiu et al., 2002; Deng et al., 2009). cAMP is known to regulate 
neurite outgrowth, i.e. administration of cAMP into the DRG can promote the regeneration of 
dorsal column axons (Neumann et al., 2002; Qiu et al., 2002). 
 
In order to try to further promote the remodeling process, we aimed in exogenously inducing 
sustained STAT3 overexpression via viral gene transfer in order to investigate if this leads to 
improved spinal remodeling. We could show that if we overexpress STAT3 genetically in the 
neurons of the corticospinal tract this promotes axonal outgrowth after SCI (Lang et al., 
2013). However, the increased CST sprouting does not lead to an increase in the number of 
contacts onto spinal relay neurons (LPSN). Why this is not the case might be due to the fact 
that the detour circuit is spontaneously formed at an optimal rate, at least in absence of 
additional manipulations which aim at inducing axonal guidance and synapse formation. 
Additionally we can show in our study, that long-lasting overexpression of STAT3 is able to 
induce outgrowth of non-injured axons. In particular, using the pyramidotomy lesion 
paradigm, in which only one  
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side of the CST is injured at the level of the medulla oblongata and the direct cortical input is 
unilaterally interrupted (Bareyre et al., 2002), we can show that the intact side is 
compensating for the loss of innervation by sending midline-sprouting collaterals to the 
denervated site. Those midline-crossing collaterals were in turn shown to contact spinal 
interneurons and motoneurons. Other manipulations have also been shown to induce 
remodeling after pyramidotomy. For example, neurotrophic factors (Zhou and Shine, 2003), 
or the inhibition of NOGO-A (Bareyre et al., 2002; Wiessner et al., 2003), a neurite outgrowth 
inhibitor, are able to induce sprouting of fibers across the midline. Also electrical stimulation 
has been shown to increase midline–crossing fibers (Brus-Ramer et al., 2007), or in 
combination with exercises improved behavioral outcome (Harel et al., 2013). Finally, 
manipulating the inhibitory milieu, i.e. degrading chrondrotin sulphate proteoglycans 
(CSPGs) via enzyme chrondrotinase ABC (ChABC), or overexpressing other proteins such as 
the neuronal calcium sensor1 (NCS1) have also promoted midline sprouting and supported 
functional recovery (Yip et al., 2010; Starkey et al., 2012).  
 
 4.1.2 STAT3 as a Therapeutic Agent: Risks and limitations 
We have demonstrated that STAT3 is a potent mediator of neurite outgrowth. However, as 
STAT3 is a pleiotropic molecule embedded in a complex signaling cascade, its sustained 
expression might also induce unwanted side effects such as cancer or inflammation which are 
discussed in short below.  
The effects of STAT3 for instance are not only restricted to neuronal cells. After a spinal cord 
injury, reactive astrocytes are migrating to the lesion site. Okada et al. (2006) could show that 
the  
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function of reactive astrocytes here are largely dependent on STAT3. Having astrocytes 
expressing STAT3 leads to the proper formation of the scar and prevents unorganized 
inflammation and reduces functional deficits (Okada et al., 2006; Herrmann et al., 2008). The 
critical point with STAT3 being applied in a non-selective way and over a longer time here 
could be the continuous activation of astrocytes that might be detrimental to axonal 
regeneration as this keeps the scar and its inhibitory environment intact. As the effects of 
STAT3 are on the transcriptional level, an upregulation can also lead to suppression of 
apoptosis because it activates genes, which in the case of an injury are pro regenerative (such 
as bcl-xl or bcl-2), but might lead to aberrant growth in other areas (Yu et al., 2009). This 
indicates that the use of STAT3 could have a high risk to induce cancer formation if not 
applied carefully.  
A very promising application could be the use of viral gene therapy (recombinant adeno – 
associated viral vectors, rAAV). Not only that these tools have been used extensively in 
animal studies, but also they are very well characterized in terms of safety and restrictiveness 
to neuronal populations, depending on their capsid structure (Xiao et al., 2012). They have 
been used for gene therapy during clinical trials, i.e. for neurodegenerative diseases such as 
Alzheimer’s disease (Lim et al., 2010) and cystric fibrosis (Moss et al., 2004; Moss et al., 
2007). Limitations to overcome, so far are the reactions of the immune system, i.e. that 
transgene-expressing cells are eliminated by the cells of the immune system (Mingozzi et al., 
2011; Rogers et al., 2011). Particularly in the case of spinal cord injury this could affect a 
stable expression of the rAVV. Here, the injury itself leads to a strong inflammatory response 
(Bareyre et al., 2003) which in addition could also “attack” the rAAVs and thereby eliminate 
transduced neuronal cells. However, efforts are taken to also overcome those difficulties. For 
example, studies are ongoing  
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in which the transduction efficacy of the vector is increased. This way, one can achieve the 
same expression levels, or higher, with a lower amount of transferred rAAV (Li et al., 2010; 
Bartel et al., 2011).  
The identification of molecules such as STAT3, which induce growth during injury-induced 
axonal remodeling, is one key step in the aim of triggering the formation of the detour circuit 
after injury. Therefore, finding additional growth promoting cues, which could trigger growth 
or be combined with STAT3 for additive effects, is of great interest for the future. 
  
4.2 Identification of the Expression of Guidance Molecules in the 
Injured Spinal Cord 
Once the growth of the de novo collaterals is induced, the axons have to be guided into their 
proper target area and form contacts onto the target cells. The second aim of my thesis was 
the identification of potential candidate molecules which can guide the axons onto the proper 
target interneurons in the spinal cord during the remodeling process. To do so, we examined 
the expression of guidance molecules which determine the formation of neuronal circuits in 
the developing nervous system, within different groups of spinal interneurons during detour 
circuit formation following spinal cord injury.  
 
4.2.1 Role of Guidance cues in the developing and in the Adult CNS 
In the human developing CNS, each of over a trillion cells has to form connections with, on 
average, over a thousand target cells. The correct connection and wiring is essential for the 
proper  
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functioning of the nervous system. To achieve this, the newly growing axons are either guided 
via contact attraction, chemoattraction, contact repulsion or chemorepulsion. The contact 
mediated repulsion or attraction is used over short range guidance, whereas the 
chemoattraction or –repulsion is usually used during long range guidance (Figure 9; for 
review see Tessier-Lavigne and Goodman, 1996).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9: Guidance forces leading the growing axon through the developing tissue. 
Attraction or repulsion occurs either via long distance (such as secreted Semaphorines) or 
via contact mediation and thereby are defined as short-range cues (such as Ephrin ligands 
or transmembrane Semaphorines). (Adapted from Tessier – Lavigne and Goodman, 1996; 
Re-print permission from the American Association for the Advancement of Science) 
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In the last years, numerous cues important for axon guidance have been identified in the 
developing nervous system. Their expression usually is depending on the phase in which the 
axon is (growing, targeting or synapsing) or in which area it is growing to (Kolodkin and 
Tessier – Lavigne, 2011; Fox and Umemori, 2006). For instance, the guiding molecule 
semaphorin 6a is expressed in the developing corticospinal tract. It is shown to only be 
expressed in the area were the tip of the growing CST axons are located, such as at embryonic 
day E17.5 in the pons, and in the inferior olives just before the pyramidal decussation at P4 
(Rünker et al., 2008). Other examples show spatially distinct expression patterns of the 
guidance cues. The Slits, repulsive guidance cues, are only located in the ventral half of the 
developing spinal cord, e.g. the floor plate (Hammond et al., 2005). Members of the Ephrin 
family, also part of the repulsive guidance cues, such as EphrinB3 is expressed in the floor 
plate, whereas EphrinB2 and B1 show expression only in the dorsal spinal cord (Jevince et al., 
2006). In contrast, our study shows a very ubiquitous distribution of the individual cues 
investigated in the adult CNS (Jacobi et al., 2014). One potential explanation for the 
differences in the expression pattern between development and adult could be a change in the 
role of the guidance cues. Axon guidance cues could switch from a repulsive to an attractive 
cue and vice versa. The expression of these cues in the adult CNS indicates that they could 
influence the stabilization of neuronal circuits during adulthood and axonal remodeling 
following injury. Some of these cues have been shown to be expressed at the lesion site after 
injury (Wehrle et al., 2005; Kopp et al., 2010). So far, the exact roles of the different cues 
investigated during my thesis are not fully understood, but their potential role during adult 
neuronal circuit formation can be strengthened by the fact, that all their receptors are also 
expressed in the layer V neurons of the motorcortex that send their axons down to the spinal 
cord and form the CST tract. These receptors have also been shown to be  
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expressed in the developing CST tract (Rünker et al., 2008; Yokoyama et al. 2001; Bagri et 
al., 2002). More experiments are warranted in order to elucidate the role of these cues in 
adulthood and following injury. 
 
4.2.2 Role of Axon Guidance Cues During Post-Injury Remodeling 
As mentioned above, the attractive and repulsive guidance cues have been studied in great 
detail during the development (Tessier-Lavigne and Goodman, 1996; Mueller et al., 1999).  
One group is the repulsive guidance cues of the slit / robo family (Slit-1,-2 and -3, and their 
receptors Robo-1,-2 and -3). First hints of this family being a negative regulator in the adult 
CNS rose after it has been shown that the slits are expressed at the lesion site after spinal cord 
injury and thereby perhaps contribute to the failure of regeneration (Wehrle et al., 2005, Lu et 
al., 2008). In our study we can show that slits are also expressed in the cervical spinal cord, in 
unlesioned and lesioned animals, remote from the lesion site. As we also show their receptors 
being expressed by the neurons of the corticospinal tract, we can assume an important role in 
the nervous system and among others after injury. Interestingly, we do observe a specific 
expression of the slit ligands in excitatory propriospinal neurons compared to inhibitory 
glycinergic interneurons (Jacobi et al., 2014). As those are specifically contacted by 
regrowing CST collaterals after injury, this might indicate a change in their role from neurite 
repulsion in development (Sang et al., 2002) to neurite attraction in adulthood (as mentioned 
above). 
Another group of guidance cues are the semaphorins and their receptors (Sema6a, -7a and 
their receptors PlexinA2 and –C1). Similarly to the slits, they have been implicated in the 
control of neuronal development (Suto et al., 2007; Rünker et al., 2008; Pasterkamp et al., 
2003; Mann et al., 2007). Also here we can show the ubiquitous expression of the two  
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ligands, sema6a and sema7a, in the cervical gray matter. The two main receptors, PlexinA2 
and PlexinC1 respectively, do also show expression in the adult cortex, as reported before 
(Shim et al., 2012; Kopp et al., 2010) and in particular in the lamina V of the motorcortex. 
Sema7a is known to be a growth promoting cue (Pasterkamp et al., 2003). After injury this 
cue is expressed by all propriospinal neurons but in only a restricted subset of glycinergic 
interneurons, indicating that this cue might help the new collaterals to grow towards the 
propriospinal neurons. It is worth noting that the injury is not accompanied by a change in the 
expression pattern of Sema7a. This is in contrast to previous findings where Sema7a 
expression is increased in neurons and components of the glial scar (Kopp et al., 2010) at the 
site of the injury. This discrepancy is most likely due to the difference in location for the 
analysis. The study of Kopp et al is performed at the site of the lesion while our study is 
performed remote from the lesion site, at the level of axonal remodeling. 
The axon guidance cues studied here have been shown to be expressed in the adult central 
nervous system, in the unlesioned and lesioned situation. The distinct expression of the 
ligands preferably on the propriospinal neurons might suggest a change in the signaling effect 
from development to adulthood for sema6a but a preserved transduction pathway for Sema7a. 
 
Taken together, the expression of the slit’s and Sema7a mainly on the excitatory spinal relay 
neurons (LPSN) but not on inhibitory, glycinergic interneurons, gives rise to a potential role 
in post-injury axonal remodeling. Further, more detailed investigations, i.e. via genetic 
manipulations (knock-out mice or viral mediated genetic overexpression), could help gaining 
a greater insight into their role in the adult CNS and after injury. 
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4.3 Identification and Molecular Modulation of Synaptogenesis during 
Injury Induced Remodeling 
The last task of my thesis was to identify molecules that could be involved in regulating 
synapse formation during post-injury axonal remodeling. We first established an in situ screen 
to identify potential candidates and then continued by manipulating one particular synaptic 
organizer in our injury model. In this chapter I will explain which synaptogenic molecules we 
investigated and will discuss how the modulation of one of them, FGF22, interferes with 
detour circuit formation following spinal cord injury. 
 
4.3.1 Role of Synaptogenic Cues During Post-Injury Remodeling 
Once the axon has reached its target cell, a synapse has to be formed in order for neuronal 
transmission to be established. This usually is induced either pre-synapticaly or post-
synapticaly (Gerrow and El-Husseini, 2006). The process of synapse formation has been 
studied extensively during development (Fox and Umemori, 2006; Biederer et al., 2006). It 
involves several molecules such as trans-synaptic adhesion molecules which span the synaptic 
cleft and are needed to precisely align pre- and postsynaptic sites.  
We first focused on Synaptic Cell Adhesion Molecules (SynCAMs), which are known to be 
crucial for the formation of new connections during development (Biederer et al., 2006). This 
family of molecules acts bi-directionally (Biederer and Stagli, 2008); therefore we analyzed 
their expression in the cortex, for the receptors, and in the spinal cord, for the ligands. We can 
detect expression of SynCAM1, 3 and 4 throughout the adult cortex (prominently in layer V) 
and the adult spinal cord which is in line with previous reports (Thomas et al., 2008; Zelano et 
al, 2009). We can show that, SynCAM1 and SynCAM3 do not show a preferential expression  
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in the different types of interneurons; however SynCAM4 is preferentially expressed in 
propriospinal neurons. The abundant expression of the SynCAMs in the spinal cord indicates 
a contribution of these molecules to the formation or maintenance of synapses in the adult 
CNS and might reveal a role in the formation of new contacts and synapses between the 
newly born CST collaterals and propriospinal interneurons after dorsal hemisection. As we 
did not detect any change in expression over time, it is unlikely that the SynCAMs, in 
particular SynCAM4 contribute to the pruning process or the maintenance and stabilization of 
synapses during injury-induced axonal remodeling.  
Next to the SynCAMs, our studies focused on other inducers of presynaptic organization - the 
neuroligins (Scheiffele et al., 2000). They are located post-synapticaly and connect to the 
postsynaptic organizers neurexins which are located pre-synapticaly (Ushkaryov et al., 1992 
and 1993). They are known to play a role in the concept of formation of new synapses during 
development of non-neuronal as well as neuronal tissue (Scheiffele eta al., 2000; Dean et al., 
2003). We were able to show, that the neuroligins, NL1 and NL4, are present in interneurons 
and motoneurons throughout the cervical gray matter of the spinal cord, which is consistent 
with previous findings showing also NL2 and NL3 being localized to motoneurons 
(Varoqueaux et al., 2006). One interesting finding of our study is the distinct expression of 
NL1 mainly in excitatory propriospinal interneurons, whereas NL4 is strongly expressed in 
the inhibitory glycinergic interneurons. NL1 is known to be an initiator for excitatory synapse 
formation (Song et al., 1999) and therefore might contribute to the establishment of excitatory 
synapses between the newly growing CST collaterals and their target cells after spinal cord 
injury. This way NL1 might play a role in the remodeling processes after injury. In another 
study from Zelano and Colleagues (2007), it could also be shown, that neuronal transection 
leads to a downregulation of neuroligin mRNA in transected neuron. In our study we could  
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not show such a downregulation following the thoracic lesion. Again, the distance between 
the lesion site and the area of investigation, as well as the fact that these interneurons are not 
directly affected by the lesion itself might explain such differences. 
The next group we investigated was the group of Ephrins and their receptors (Ephs). This 
family has been found to be involved in several developmental processes such as cell 
migration, axon guidance and the neuronal organization of the CNS (Klein, 2004). Their role 
in targeting has been shown in studies which investigated the development of the visual 
system and the development of the corticospinal tract (Nakagawa et al., 2000; Williams et al., 
2003; Yokoyama et al., 2001). The first study revealing the role of ephrinB-ephB signaling in 
synapse formation was presented by Greenberg and Colleagues in 2000. Here they show that 
ephrinBs induce glutamate receptor clustering. Following studies showed, i.e. that 
hippocampal neurons, lacking ephB1-3, exhibit smaller postsynaptic components and smaller 
postsynaptic densities (Henkemeyer et al., 2003). In our study we were able to show for the 
first time the expression of ephrinB1 and its receptor ephB2 in spinal interneurons. So far, 
ephrinB1 and ephB2 have only been shown in the white matter, as well as in meningeal cells 
and astrocytes before and after SCI (Budensen et al., 2003). Similar to the SynCAMs, they are 
known to be bidirectional inducers of synapse formation and therefore we detected the 
receptors and ligands in the cortex, which is consistent with previous findings (Moreno-Flores 
et al., 1999; Wang et al., 2005). The abundant and constantly unaffected expression of 
ephrinB1 and ephB2 in interneurons of the cervical spinal cord before and after SCI indicates 
a similar role for those cues as for the SynCAMs. They might be important contributors of the 
establishment of functional synapses but are most probably not participating in the 
stabilization of those contacts.  
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4.3.2 Role of FGF Signaling during Development and Adulthood  
The last group of synaptogenic molecules we focused on is the family of the fibroblast growth 
factors (FGFs). The FGF family is a very well-known group of secreted molecules, which are 
important in various organs during embryonic development (for review see Ornitz and Itoh, 
2001), i.e. FGF10 has been shown to play a role in wound healing (Tagashira et al., 1997) or 
development of the limbs and lung (Martin, 1998; Bellusci et al., 1997).  In 2004, Umemori et 
al. identified for the first time FGF22 and its close relatives, FGF7 and -10, as inducers of 
presynaptic differentiation via signaling through their main receptor FGFR2b, during 
neuronal development (Ornitz et al., 1996). The authors show that i.e. FGF22 is able to induce 
clustering of synaptic vesicles and neurite branching in vitro and in vivo (Umemori et al., 
2004). This function is specific to FGFR2b but not the other main isoform of the FGF 
receptor, FGFR2c. Later it has been shown that FGFR1b also shows a specific binding 
affinity to FGF22, albeit not as strong as FGFR2b (Zhang et al., 2006). Another study in 2010 
shows how FGF22 and FGF7 promote the organization of excitatory and inhibitory 
presynaptic terminals, respectively, during the development of CA3 hippocampal pyramidal 
neurons (Terauchi et al., 2010). The involvement of this FGF family in presynaptic 
differentiation has also been shown in the development of neuromuscular junctions in the 
mouse (Fox et al., 2007). However, the presence and role of FGF22 and its receptors in the 
adult CNS, also in the context of the detour circuit after injury, has not been investigated so 
far. 
In our study we can show, that FGF22 and its receptors, FGFR1 and FGFR2, are also 
expressed in the adult CNS. FGF22 is expressed ubiquitously in the cells of the spinal cord, 
whereas the receptors show a distinct expression in the cortex, in particular in layer V of the  
128 
 
                      Chapter 4 
cortex. The fact that FGF22 and its receptors are expressed in the adult CNS indicates that 
they could play a role in adulthood and particularly during detour circuit formation. We also 
show that a lesion to the spinal cord does not alter the expression of the ligand, FGF22, distal 
to the lesion site. As with the synaptogenic cues investigated in our previous paper (Jacobi et 
al., 2014), we can assume, that the effect of the lesion onto the expression of the FGF22 
ligand and its receptors might only be minimal because of the distance of the observed area to 
the lesion site. It is important to note that a conditional ablation of one of the receptors does 
not lead to compensation by an increased expression of the other receptor after injury. It 
might indicate that those two receptors have slightly different function.  
4.3.3 Role of FGF Signaling following Injury  
 To identify an involvement of FGF22 and / or its receptors in the process of detour circuit 
formation, we took advantage of several approaches. First, we analyzed mice with a genetic 
ablation of FGF22 (FGF22 KO). Second, we genetically ablated either of the receptors in the 
cells of layer V of the cortex (origin of the CST) by crossing a floxed mouse line (FGFR1fl/fl 
or FGFR2fl/fl) with an EMX1-Cre mouse line. Because the EMX1 promoter drives the 
expression of the Cre recombinase in the forebrain, this leads to the specific deletion of the 
FGF receptors in the forebrain and hence in the CST as of E10. Finally, we deleted each of 
the receptor separately or we co-deleted both receptors in the neurons of the hindlimbCST via 
gene-therapy using adeno-associated viruses expressing the Cre recombinase (See also 
Manuscript 3). We can show that the deletion of the ligand and the receptors leads to a drastic 
reduction of boutons on newly formed collaterals during injury-induced detour circuit 
formation. In mice deleted of one FGF22 receptors, we could also show that complexity of 
the new collaterals is reduced – an additional marker for neuronal plasticity (Shen and 
Cowan, 2010). A reduction in the number of boutons indicates that contact-induced  
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presynaptic differentiation is less efficient in these mice. Both, a deletion in the receptors or 
of the ligand, seem to inhibit synaptic bouton formation. This is in contrast to the study of 
Terauchi et al., 2010, who show that in the CA3 of the hippocampus the KO of FGF22 does 
not alter the number of asymmetric excitatory synapses but only the vesicle recruitment. 
However they also show, that already in the adjacent area, CA1, the FGF signaling 
mechanism is not required for synapse formation, thus indicating that the effect of FGF 
signaling can be very specific to the type of cells, the area and the time point.   
The loss of either of the receptors, FGFR1 or FGFR2, also shows an interesting side effect. 
Knocking out the receptors as early as embryonic day E10, leads to an increased sprouting of 
the corticospinal tract after spinal cord injury. This suggests that FGF22 signaling via either 
receptor participates in the induction of compensatory CST sprouting. Co-deletion of the two 
FGF receptors and deletion of FGF22 before the injury did not lead to such an increased 
sprouting while the synapse formation and maturation was strongly reduced. One possible 
explanation could be that there is activation of a different signaling pathway via one or the 
other of the receptors (Guillemot and Zimmer, 2011). Also, it is not known if the different 
receptors are able to dimerize with each other and in this case, FGFR1-FGFR2 interaction 
could activate another pathway.  
We also characterized the maturation of the boutons on de novo CST collaterals in the 
cervical spinal cord of our different mouse lines following spinal cord injury. We can show 
that markers for early and late synapse maturation, Bassoon and Synapsin respectively (Zhai 
et al., 2000; Lang et al., 2012), are differentially expressed at different time points. Bassoon 
expression, a marker for the active zone in the synapse (Schoch and Gundelfinger, 2006), is 
reduced in the boutons of CST collaterals of the FGF22 KO and FGFR co-deletion mice 
shortly after lesion and only goes back to baseline levels in the FGF22KO at the later time  
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point, when the detour circuit is fully established (12wks). In FGFR co-deleted mice, Bassoon 
labeling remained significantly below control even 12wks following the lesion. For Synapsin, 
a vesicle marker which stands for more mature boutons (Lang et al., 2012), the boutons in the 
different types of KO show a decreased labeling at early time points as well as at later time 
points, with an exception of the single KO of FGFR1.  
These results indicate that inactivating FGF signaling prevents presynaptic differentiation by 
blocking active zone formation and vesicle clustering at early and late stages of detour circuit 
formation rather than just delaying it. This is in agreement with another study where this 
blockade is shown in the postnatal development of hippocampal CA3 neurons (Terauchi et 
al., 2010).   
4.3.4 Impaired FGF Signaling Delays Functional Recovery after 
Injury: a Potential Therapeutic Target? 
In our study we can show, that the co-deletion of both receptors, FGFR1 and FGFR2, or the 
ligand, FGF22, results in a drastic decrease of the contacts onto the LPSN. To test how this 
affects functional recovery, we performed various behavioral tests (Figure 10). The BMS test 
is an open field test, in which the mice are under observation while exploring a certain area. It 
is a gross locomotor test which is commonly used to observe the recovery of the animals 
following spinal cord lesion. The Ladder Rung Test is reflective of the thin locomotion 
abilities of the animal and is highly CST specific in particular when an irregular spacing of 
the bars is used. Indeed, it tests the ability of the mouse to place its hindlimbs onto the bars of 
the ladder and therefore is a very good behavioral assessment of CST related functional 
recovery and detour circuit formation after injury. We can see that control mice recover 
gradually some motor function over the course of 3 weeks. However, we found that  
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FGF22KO and FGFR1-R2 co-deleted mice could not recover as well as the control mice and 
remained impaired over the weeks following the injury. In particular in the irregular walk, in 
which the mice have to pass the ladder rung with altering bars and gaps between those, the 
FGF22 KO and the FGFR1-R2 co-deleted mice perform a lot worse than their controls. 
 
       
 
 
 
 
 
 
 
 
 
These results show a potential effect of a FGF22 overexpression on recovery after SCI in 
wildtype mice. Trying to overexpress FGF22 in the LPSN of the cervical spinal cord of 
normal wildtype mice could have a positive effect on recovery after injury and maybe also 
increase axonal remodeling. To test this, we now created a virus (rAAV) which carries the 
FGF22 sequence and inject this virus into C3-C5, the area in which the cell bodies of the 
LPSN are located (Alstermark et al., 1987). After an incomplete spinal cord injury, we would 
like to investigate if the establishment of the detour circuit is strengthened by additional 
contacts onto the LPSN, or fastened by a quicker formation of the full circuit, i.e. already after 
two weeks (with growth rate being the limiting factor here). Also the overexpression of 
FGF22 could lead to a quicker maturation of the synapses, as we show in our study that this  
Figure 10; Behavioral Tests to record functional recovery after SCI. A) BMS (Basso Mouse 
Scale for locomotion, Basso et al., 2006)) is an open field test in which the mouse is scored under 
different points, i.e. limb movement, trunk support, tail movement, according to its performance 
after injury. B) Ladder Rung (Grid Walk; Metz and Whishaw, 2009) is a horizontal ladder which 
the mice have to pass. While doing so the number of foot falls is acquired and compared. The 
placement of the paws is a very CST specific function. 
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maturation is impaired in the FGF22 KO mice. These ongoing investigations will help us 
finding out if FGF22 can act as a potential therapeutic target after injury. 
However, one also has to keep in mind that some FGF family members and their 
overexpression or activation-mutations have been shown to induce various kinds of tumors 
and cancer in humans (Turner and Grose, 2010; Brooks et al., 2012). The persistent and 
excessive activation of the FGFR signaling pathway for example can result in carcinogenic 
functions in the cells and thereby end in excessive proliferation and apoptosis (Greulich et al., 
2012). Also in the CNS, the FGF family has been shown to lead to several types of tumors, 
i.e. gliomas and meningiomas (Takahashi et al., 1990) or astrocytomas (Morrison et al., 
1994). Even though there is nothing known about FGF22 in CNS tumor development, one has 
to keep this strong proliferation potential in mind that is activated by overexpression of FGFs 
and has to be careful when performing experiments using FGF22 to increase axonal 
remodeling after injury.  
More recently the FGFs have also been shown to play a role in a different disease – epilepsy 
(for review see, Paradiso et al., 2013). In particular, FGF22 has been shown to be a potential 
target of therapy for epilepsy (Lee and Umemori, 2013). The authors show in their study that 
the FGF22 KO mice exhibit resistance to kindling generated epileptic seizures. The mice 
don’t show the typical pathological events such as increased neurogenesis, ectopic migration 
of dendate gyrus cells (DGC) or hilar cell death after a seizure. This suggests the possibility 
that inhibiting FGF22 signaling in the hippocampus might alleviate epileptogenesis. 
The results obtained during my thesis suggest that i.e. STAT3 or FGF22 could be 
valuable therapeutic candidates for the induction of growth (STAT3) or the efficient 
establishment and maturation of synapses (FGF22), hence axonal remodeling following SCI.  
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The work carried out during my thesis also suggests that some other molecules, such as 
Sema7a (Jacobi et al., 2014) for example could be important for the correct targeting of detour 
circuits following injury. 
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5.  Conclusions 
 
Axonal remodeling after spinal cord injury is a key feature that contributes to functional 
recovery (Fouad et al., 2001; Bareyre et al., 2004; Courtine et al., 2008; van den Brand et al., 
2012). After an incomplete spinal cord injury, axonal detour circuits have been shown to 
contribute to this functional recovery. This axonal remodeling is divided into three different 
phases, (i) the initiation of growth, (ii) the formation of collaterals which are guided into a 
certain target area and (iii) the formation of contacts and the followed refinement of those 
onto the target cells.  
In my thesis, I was trying to find molecules which regulate the different phases of the 
formation of this detour circuit in order to better understand the underlying mechanisms of 
axonal remodeling. This could help guiding future studies and help finding therapeutic targets 
to support recovery and thereby prevent the devastating consequences after injury.  
Looking at the research that has been done in the last years, it has become clearer that 
manipulation of a single molecule will not be sufficient to achieve successful recovery, but 
rather a combination of the manipulation of several cues. This also underlies the need of a 
combination of therapeutic interventions to overcome the lack of recovery such as gene 
therapy, physiotherapy or electrical stimulation. The field of spinal cord injury research has 
evolved very quickly in the last years, and thanks to progresses in many different 
experimental techniques such as in vivo imaging, electrophysiology, transgenic technologies 
or optogenetics, the chances of establishing experimentally combined therapies that could 
then be translated to help patients with SCI are coming closer and more realistic.     
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